| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | molecular adaptor activity | BCL9L DLG5 ABL1 SH3RF1 NELFA NACA DTL KSR2 BCORL1 E2F1 CHD4 BCL9 SRCAP CREBBP KSR1 IGF2BP1 MIDN SNAP91 ABI2 TIRAP ZMIZ2 EIF4G1 MAMSTR JAZF1 KDM2B RCOR3 MAML2 FLRT2 SCRIB MED12 | 8.77e-08 | 1356 | 151 | 30 | GO:0060090 |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | BCL9L DLG5 ABL1 SH3RF1 NACA DTL KSR2 BCORL1 CHD4 BCL9 SRCAP CREBBP KSR1 IGF2BP1 SNAP91 ABI2 TIRAP ZMIZ2 MAMSTR JAZF1 KDM2B RCOR3 MAML2 FLRT2 SCRIB MED12 | 5.74e-07 | 1160 | 151 | 26 | GO:0030674 |
| GeneOntologyMolecularFunction | transcription coregulator activity | BCL9L ABL1 NACA BCORL1 CHD4 BCL9 SRCAP CREBBP ZMIZ2 MAMSTR JAZF1 KDM2B RCOR3 MAML2 MED12 | 2.44e-05 | 562 | 151 | 15 | GO:0003712 |
| GeneOntologyMolecularFunction | signaling adaptor activity | 5.69e-05 | 129 | 151 | 7 | GO:0035591 | |
| GeneOntologyMolecularFunction | MAP-kinase scaffold activity | 1.15e-04 | 13 | 151 | 3 | GO:0005078 | |
| GeneOntologyMolecularFunction | mitogen-activated protein kinase kinase binding | 3.76e-04 | 19 | 151 | 3 | GO:0031434 | |
| GeneOntologyMolecularFunction | transcription coactivator activity | 5.10e-04 | 303 | 151 | 9 | GO:0003713 | |
| GeneOntologyMolecularFunction | cytoskeletal regulatory protein binding | 5.60e-04 | 5 | 151 | 2 | GO:0005519 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 5.79e-04 | 188 | 151 | 7 | GO:0005201 | |
| GeneOntologyMolecularFunction | SH3 domain binding | 7.72e-04 | 143 | 151 | 6 | GO:0017124 | |
| GeneOntologyBiologicalProcess | regulation of synapse organization | DLG5 CUX2 CTTNBP2 ABL1 MAP1B PODXL DAB1 CC2D1A CHD4 ARHGEF15 SNAP91 ABI2 EIF4G1 FLRT2 AGRN | 1.71e-07 | 387 | 151 | 15 | GO:0050807 |
| GeneOntologyBiologicalProcess | regulation of synapse structure or activity | DLG5 CUX2 CTTNBP2 ABL1 MAP1B PODXL DAB1 CC2D1A CHD4 ARHGEF15 SNAP91 ABI2 EIF4G1 FLRT2 AGRN | 2.22e-07 | 395 | 151 | 15 | GO:0050803 |
| GeneOntologyBiologicalProcess | regulation of cell junction assembly | DLG5 CUX2 ABL1 MAP1B PODXL CC2D1A CHD4 IRX3 ARHGEF15 EIF4G1 FLRT2 AGRN PHLDB2 | 4.69e-07 | 309 | 151 | 13 | GO:1901888 |
| GeneOntologyBiologicalProcess | cell junction assembly | DLG5 CUX2 ABL1 MAP1B PODXL SH3BP1 NFASC CC2D1A CHD4 IRX3 ARHGEF15 ABI2 EIF4G1 FLRT2 BSN AGRN PHLDB2 | 9.74e-07 | 569 | 151 | 17 | GO:0034329 |
| GeneOntologyBiologicalProcess | positive regulation of cellular component biogenesis | DLG5 CUX2 ABL1 MAP1B IRX3 ARHGEF15 MAP3K1 PPP2R5B SNAP91 ABI2 UBAP2L TIRAP EIF4G1 ULK1 FLRT2 AGRN PHLDB2 | 1.33e-06 | 582 | 151 | 17 | GO:0044089 |
| GeneOntologyBiologicalProcess | regulation of synapse assembly | DLG5 CUX2 MAP1B PODXL CC2D1A CHD4 ARHGEF15 EIF4G1 FLRT2 AGRN | 2.46e-06 | 202 | 151 | 10 | GO:0051963 |
| GeneOntologyBiologicalProcess | cell junction organization | DLG5 CUX2 CTTNBP2 ABL1 MAP1B PODXL SH3BP1 DAB1 PTPN23 NFASC CC2D1A CHD4 IRX3 PPFIA3 ARHGEF15 SNAP91 ABI2 EIF4G1 FLRT2 BSN AGRN PHLDB2 | 2.50e-06 | 974 | 151 | 22 | GO:0034330 |
| GeneOntologyBiologicalProcess | synapse organization | DLG5 CUX2 CTTNBP2 ABL1 MAP1B PODXL DAB1 NFASC CC2D1A CHD4 PPFIA3 ARHGEF15 SNAP91 ABI2 EIF4G1 FLRT2 BSN AGRN | 2.84e-06 | 685 | 151 | 18 | GO:0050808 |
| GeneOntologyBiologicalProcess | synapse assembly | DLG5 CUX2 MAP1B PODXL CC2D1A CHD4 ARHGEF15 EIF4G1 FLRT2 BSN AGRN | 1.73e-05 | 308 | 151 | 11 | GO:0007416 |
| GeneOntologyBiologicalProcess | regulation of cellular component biogenesis | DLG5 CUX2 ABL1 MAP1B PODXL TBC1D2B CC2D1A CHD4 IRX3 ARHGEF15 MAP3K1 PPP2R5B MEGF9 SNAP91 ABI2 UBAP2L TIRAP EIF4G1 SEC16A ULK1 FLRT2 AGRN PHLDB2 | 1.83e-05 | 1189 | 151 | 23 | GO:0044087 |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | BCL9L SFPQ ABL1 NELFA NACA POU2F2 E2F1 POGZ IRX3 KDM6B BCL9 CREBBP MAP3K1 PRDM2 MLXIPL PPP2R5B ARID2 ZMIZ2 MAMSTR ZFHX3 MAML2 NKX6-1 ZNF319 AGRN MED12 | 2.59e-05 | 1390 | 151 | 25 | GO:0045944 |
| GeneOntologyBiologicalProcess | small GTPase-mediated signal transduction | ABL1 RASGRF2 ARHGAP10 RGL3 KSR2 SH3BP1 DAB1 ARHGEF15 KSR1 ABI2 RIPOR1 ULK1 AGRN SOS2 | 4.28e-05 | 538 | 151 | 14 | GO:0007264 |
| GeneOntologyBiologicalProcess | zonula adherens assembly | 5.32e-05 | 2 | 151 | 2 | GO:0045186 | |
| GeneOntologyBiologicalProcess | stem cell population maintenance | 6.43e-05 | 237 | 151 | 9 | GO:0019827 | |
| GeneOntologyBiologicalProcess | double-strand break repair via homologous recombination | 7.51e-05 | 188 | 151 | 8 | GO:0000724 | |
| GeneOntologyBiologicalProcess | maintenance of cell number | 7.55e-05 | 242 | 151 | 9 | GO:0098727 | |
| GeneOntologyBiologicalProcess | recombinational repair | 9.35e-05 | 194 | 151 | 8 | GO:0000725 | |
| GeneOntologyBiologicalProcess | neuron migration | 2.09e-04 | 218 | 151 | 8 | GO:0001764 | |
| GeneOntologyCellularComponent | Golgi lumen | 6.22e-09 | 109 | 150 | 10 | GO:0005796 | |
| GeneOntologyCellularComponent | glutamatergic synapse | DLG5 CTTNBP2 MAP1B RASGRF2 PODXL DAB1 ANKS1B CC2D1A CHD4 PPFIA3 ARHGEF15 ABI2 PIK3C3 PLEKHA5 FLRT2 SCRIB BSN AGRN | 2.37e-05 | 817 | 150 | 18 | GO:0098978 |
| GeneOntologyCellularComponent | nuclear protein-containing complex | BCL9L CASC3 SFPQ NELFA UBQLN4 E2F1 CHD4 NUP214 KDM6B BCL9 SRCAP CREBBP PHF21A MLXIPL UBAP2L ARID2 NPAP1 SUGP1 KDM2B RCOR3 SAP130 MED12 SYMPK RAD23B | 4.59e-05 | 1377 | 150 | 24 | GO:0140513 |
| GeneOntologyCellularComponent | mucus layer | 1.53e-04 | 3 | 150 | 2 | GO:0070701 | |
| GeneOntologyCellularComponent | cell leading edge | ABL1 SH3RF1 WIPF1 PODXL SH3BP1 KSR1 IGF2BP1 ABI2 TIRAP RIPOR1 SCRIB PHLDB2 | 2.68e-04 | 500 | 150 | 12 | GO:0031252 |
| GeneOntologyCellularComponent | nuclear body | PABIR1 CASC3 SFPQ ABL1 CIART NELFA ZC3H13 ANKS1B PTPN23 SRCAP CREBBP REXO1 PYHIN1 ZFHX3 MAML2 SAP130 SYMPK | 2.69e-04 | 903 | 150 | 17 | GO:0016604 |
| GeneOntologyCellularComponent | histone deacetylase complex | 3.68e-04 | 85 | 150 | 5 | GO:0000118 | |
| GeneOntologyCellularComponent | cytoplasmic stress granule | 6.44e-04 | 96 | 150 | 5 | GO:0010494 | |
| GeneOntologyCellularComponent | presynaptic endosome | 1.05e-03 | 7 | 150 | 2 | GO:0098830 | |
| GeneOntologyCellularComponent | ribonucleoprotein granule | 1.12e-03 | 287 | 150 | 8 | GO:0035770 | |
| GeneOntologyCellularComponent | transcription regulator complex | BCL9L SFPQ RBL2 E2F1 CHD4 BCL9 CREBBP MLXIPL ARID2 JAZF1 RCOR3 ZFHX3 | 1.25e-03 | 596 | 150 | 12 | GO:0005667 |
| HumanPheno | Restricted or repetitive behaviors or interests | CUX2 MAP1B RBL2 BCORL1 POGZ HUWE1 SRCAP CREBBP CIC MLXIPL UBAP2L ARID2 SLC45A1 MED12 | 5.40e-06 | 368 | 49 | 14 | HP:0031432 |
| HumanPheno | Disinhibition | CUX2 MAP1B PODXL RBL2 BCORL1 TBC1D2B NFASC CC2D1A POGZ HUWE1 KDM6B SRCAP CREBBP CIC PHF21A MLXIPL UBAP2L ARID2 EIF4G1 NPAP1 MED12 | 5.65e-06 | 807 | 49 | 21 | HP:0000734 |
| HumanPheno | Inappropriate behavior | CUX2 MAP1B PODXL RBL2 BCORL1 TBC1D2B NFASC CC2D1A POGZ HUWE1 KDM6B SRCAP CREBBP CIC PHF21A MLXIPL UBAP2L ARID2 EIF4G1 NPAP1 MED12 | 5.65e-06 | 807 | 49 | 21 | HP:0000719 |
| HumanPheno | Abnormal response to social norms | CUX2 MAP1B PODXL RBL2 BCORL1 TBC1D2B NFASC CC2D1A POGZ HUWE1 KDM6B SRCAP CREBBP CIC PHF21A MLXIPL UBAP2L ARID2 EIF4G1 NPAP1 MED12 | 5.65e-06 | 807 | 49 | 21 | HP:5200123 |
| HumanPheno | Social disinhibition | CUX2 MAP1B PODXL RBL2 BCORL1 TBC1D2B NFASC CC2D1A POGZ HUWE1 KDM6B SRCAP CREBBP CIC PHF21A MLXIPL UBAP2L ARID2 EIF4G1 NPAP1 MED12 | 5.65e-06 | 807 | 49 | 21 | HP:5200029 |
| HumanPheno | Reduced impulse control | CUX2 MAP1B PODXL RBL2 BCORL1 TBC1D2B NFASC CC2D1A POGZ HUWE1 KDM6B SRCAP CREBBP CIC PXK PHF21A MLXIPL UBAP2L ARID2 EIF4G1 NPAP1 JAZF1 AGRN MED12 | 5.95e-06 | 1032 | 49 | 24 | HP:5200045 |
| HumanPheno | Perseverative thought | CUX2 MAP1B RBL2 BCORL1 POGZ HUWE1 SRCAP CREBBP CIC MLXIPL UBAP2L ARID2 SLC45A1 MED12 | 7.16e-06 | 377 | 49 | 14 | HP:0030223 |
| HumanPheno | Hyperactivity | CUX2 MAP1B BCORL1 TBC1D2B CC2D1A POGZ HUWE1 KDM6B SRCAP CREBBP CIC PHF21A MLXIPL UBAP2L ARID2 NPAP1 MED12 | 8.34e-06 | 558 | 49 | 17 | HP:0000752 |
| HumanPheno | Disordered formal thought process | CUX2 MAP1B RBL2 BCORL1 POGZ HUWE1 SRCAP CREBBP CIC MLXIPL UBAP2L ARID2 SLC45A1 MED12 | 9.43e-06 | 386 | 49 | 14 | HP:0025769 |
| HumanPheno | Compulsive behaviors | 1.50e-05 | 158 | 49 | 9 | HP:0000722 | |
| HumanPheno | Abnormal thought pattern | CUX2 MAP1B RBL2 BCORL1 POGZ HUWE1 SRCAP CREBBP CIC MLXIPL UBAP2L ARID2 SLC45A1 MED12 | 1.59e-05 | 404 | 49 | 14 | HP:5200269 |
| HumanPheno | Abnormally increased volition | CUX2 MAP1B PODXL RBL2 BCORL1 TBC1D2B NFASC CC2D1A POGZ HUWE1 KDM6B SRCAP CREBBP CIC PHF21A MLXIPL UBAP2L ARID2 EIF4G1 NPAP1 MED12 | 1.86e-05 | 869 | 49 | 21 | HP:5200263 |
| HumanPheno | Impairment in personality functioning | CUX2 MAP1B PODXL RBL2 BCORL1 TBC1D2B NFASC CC2D1A POGZ HUWE1 KDM6B SRCAP CREBBP CIC PXK PHF21A MLXIPL UBAP2L ARID2 EIF4G1 NPAP1 JAZF1 SLC45A1 MED12 | 3.59e-05 | 1141 | 49 | 24 | HP:0031466 |
| HumanPheno | Abnormal social development | CUX2 MAP1B PODXL RBL2 BCORL1 TBC1D2B NFASC CC2D1A POGZ HUWE1 KDM6B SRCAP CREBBP CIC PHF21A MLXIPL UBAP2L ARID2 EIF4G1 NPAP1 MED12 | 3.71e-05 | 908 | 49 | 21 | HP:0025732 |
| HumanPheno | Recurrent maladaptive behavior | CUX2 MAP1B PODXL RBL2 BCORL1 TBC1D2B NFASC CC2D1A POGZ HUWE1 KDM6B SRCAP CREBBP CIC PXK PHF21A MLXIPL UBAP2L ARID2 EIF4G1 NPAP1 JAZF1 SLC45A1 AGRN MED12 | 9.66e-05 | 1293 | 49 | 25 | HP:5200241 |
| HumanPheno | Long fingers | ABL1 MAP1B NELFA SPEG BCORL1 CHD4 HUWE1 CIC PHF21A MED12 CNOT3 | 1.14e-04 | 306 | 49 | 11 | HP:0100807 |
| HumanPheno | Clinodactyly | ABL1 MAP1B HUWE1 KDM6B SRCAP CREBBP PHF21A MLXIPL UBAP2L ARID2 NPAP1 DLEC1 MED12 CNOT3 SOS2 | 2.02e-04 | 574 | 49 | 15 | HP:0030084 |
| HumanPheno | Congenital abnormal hair pattern | NELFA RBL2 HUWE1 SRCAP CREBBP UBAP2L ARID2 NPAP1 MED12 CNOT3 SOS2 | 2.06e-04 | 327 | 49 | 11 | HP:0011361 |
| HumanPheno | Frontal upsweep of hair | 2.52e-04 | 33 | 49 | 4 | HP:0002236 | |
| HumanPheno | Heterotropia | KIF21A BCORL1 TBC1D2B POGZ HUWE1 KDM6B UBAP2L NPAP1 AGRN MED12 | 2.68e-04 | 281 | 49 | 10 | HP:0032012 |
| HumanPheno | Abnormal finger morphology | ABL1 RSPH4A MAP1B NELFA SPEG KIF21A BCORL1 TBC1D2B NFASC MUC5B CHD4 POGZ HUWE1 KDM6B SRCAP CREBBP CIC PHF21A MLXIPL UBAP2L ARID2 NPAP1 MED12 CNOT3 SOS2 | 3.16e-04 | 1385 | 49 | 25 | HP:0001167 |
| HumanPheno | Abnormality of the hairline | 3.86e-04 | 294 | 49 | 10 | HP:0009553 | |
| Domain | VWF_type-D | 1.11e-07 | 16 | 146 | 5 | IPR001846 | |
| Domain | VWFD | 1.11e-07 | 16 | 146 | 5 | PS51233 | |
| Domain | VWD | 1.11e-07 | 16 | 146 | 5 | SM00216 | |
| Domain | VWD | 1.11e-07 | 16 | 146 | 5 | PF00094 | |
| Domain | C8 | 1.69e-06 | 12 | 146 | 4 | PF08742 | |
| Domain | TIL | 1.69e-06 | 12 | 146 | 4 | PF01826 | |
| Domain | Unchr_dom_Cys-rich | 2.43e-06 | 13 | 146 | 4 | IPR014853 | |
| Domain | C8 | 2.43e-06 | 13 | 146 | 4 | SM00832 | |
| Domain | TIL_dom | 3.38e-06 | 14 | 146 | 4 | IPR002919 | |
| Domain | WxxW_domain | 9.20e-06 | 6 | 146 | 3 | IPR025155 | |
| Domain | Mucin2_WxxW | 9.20e-06 | 6 | 146 | 3 | PF13330 | |
| Domain | CTCK_1 | 1.01e-05 | 18 | 146 | 4 | PS01185 | |
| Domain | VWC_out | 1.27e-05 | 19 | 146 | 4 | SM00215 | |
| Domain | UBA | 3.21e-05 | 47 | 146 | 5 | PS50030 | |
| Domain | Cys_knot_C | 3.99e-05 | 25 | 146 | 4 | IPR006207 | |
| Domain | CTCK_2 | 3.99e-05 | 25 | 146 | 4 | PS01225 | |
| Domain | BCL9 | 6.07e-05 | 2 | 146 | 2 | PF11502 | |
| Domain | KSR1-SAM | 6.07e-05 | 2 | 146 | 2 | PF13543 | |
| Domain | Bcl-9 | 6.07e-05 | 2 | 146 | 2 | IPR015668 | |
| Domain | BCL9_beta-catenin-bd_dom | 6.07e-05 | 2 | 146 | 2 | IPR024670 | |
| Domain | KSR_SAM-like_dom | 6.07e-05 | 2 | 146 | 2 | IPR025561 | |
| Domain | UBA | 8.38e-05 | 30 | 146 | 4 | SM00165 | |
| Domain | Ras_G-nucl-exch_fac_CS | 1.60e-04 | 14 | 146 | 3 | IPR019804 | |
| Domain | SEA | 1.60e-04 | 14 | 146 | 3 | SM00200 | |
| Domain | UBA | 1.74e-04 | 36 | 146 | 4 | PF00627 | |
| Domain | VWFC_1 | 1.74e-04 | 36 | 146 | 4 | PS01208 | |
| Domain | Sec16_C | 1.81e-04 | 3 | 146 | 2 | PF12931 | |
| Domain | ACE1_Sec16_Sec31 | 1.81e-04 | 3 | 146 | 2 | IPR024298 | |
| Domain | VWFC_2 | 2.15e-04 | 38 | 146 | 4 | PS50184 | |
| Domain | VWC | 2.15e-04 | 38 | 146 | 4 | SM00214 | |
| Domain | VWF_dom | 3.18e-04 | 42 | 146 | 4 | IPR001007 | |
| Domain | UBA | 3.82e-04 | 44 | 146 | 4 | IPR015940 | |
| Domain | - | 3.92e-04 | 283 | 146 | 9 | 1.10.10.60 | |
| Domain | RasGEFN | 4.84e-04 | 20 | 146 | 3 | SM00229 | |
| Domain | PH_dom-like | RASGRF2 ARHGAP10 TBC1D2B DAB1 ANKS1B TNS2 PLEKHN1 ARHGEF15 PLEKHA5 PHLDB2 SOS2 | 5.31e-04 | 426 | 146 | 11 | IPR011993 |
| Domain | RasGEF_N | 5.61e-04 | 21 | 146 | 3 | PF00618 | |
| Domain | Ras-like_Gua-exchang_fac_N | 6.46e-04 | 22 | 146 | 3 | IPR000651 | |
| Domain | SEA | 6.46e-04 | 22 | 146 | 3 | PF01390 | |
| Domain | RASGEF_NTER | 6.46e-04 | 22 | 146 | 3 | PS50212 | |
| Domain | CT | 6.46e-04 | 22 | 146 | 3 | SM00041 | |
| Domain | Homeobox_CS | 6.57e-04 | 186 | 146 | 7 | IPR017970 | |
| Domain | SEA | 7.39e-04 | 23 | 146 | 3 | PS50024 | |
| Domain | SEA_dom | 7.39e-04 | 23 | 146 | 3 | IPR000082 | |
| Domain | SURP | 8.92e-04 | 6 | 146 | 2 | PS50128 | |
| Domain | Surp | 8.92e-04 | 6 | 146 | 2 | PF01805 | |
| Domain | SWAP | 8.92e-04 | 6 | 146 | 2 | SM00648 | |
| Domain | Surp | 8.92e-04 | 6 | 146 | 2 | IPR000061 | |
| Domain | - | RASGRF2 ARHGAP10 TBC1D2B DAB1 ANKS1B TNS2 PLEKHN1 PLEKHA5 PHLDB2 SOS2 | 1.02e-03 | 391 | 146 | 10 | 2.30.29.30 |
| Domain | RASGEF | 1.07e-03 | 26 | 146 | 3 | PS00720 | |
| Domain | Homeodomain-like | 1.22e-03 | 332 | 146 | 9 | IPR009057 | |
| Domain | ARM-type_fold | 1.41e-03 | 339 | 146 | 9 | IPR016024 | |
| Domain | - | 1.47e-03 | 106 | 146 | 5 | 1.10.150.50 | |
| Domain | RASGEF_CAT | 1.47e-03 | 29 | 146 | 3 | PS50009 | |
| Domain | UBA-like | 1.58e-03 | 64 | 146 | 4 | IPR009060 | |
| Domain | RasGEF | 1.63e-03 | 30 | 146 | 3 | PF00617 | |
| Domain | - | 1.63e-03 | 30 | 146 | 3 | 1.10.840.10 | |
| Domain | RASGEF_cat_dom | 1.63e-03 | 30 | 146 | 3 | IPR001895 | |
| Domain | RasGEF | 1.63e-03 | 30 | 146 | 3 | SM00147 | |
| Domain | Ras_GEF_dom | 1.63e-03 | 30 | 146 | 3 | IPR023578 | |
| Domain | SAM_1 | 1.98e-03 | 68 | 146 | 4 | PF00536 | |
| Domain | SAM/pointed | 2.26e-03 | 117 | 146 | 5 | IPR013761 | |
| Domain | Homeobox | 2.46e-03 | 234 | 146 | 7 | PF00046 | |
| Domain | HOMEOBOX_1 | 2.58e-03 | 236 | 146 | 7 | PS00027 | |
| Domain | STI1 | 2.62e-03 | 10 | 146 | 2 | SM00727 | |
| Domain | STI1_HS-bd | 2.62e-03 | 10 | 146 | 2 | IPR006636 | |
| Domain | HOX | 2.65e-03 | 237 | 146 | 7 | SM00389 | |
| Domain | HOMEOBOX_2 | 2.77e-03 | 239 | 146 | 7 | PS50071 | |
| Domain | Homeobox_dom | 2.77e-03 | 239 | 146 | 7 | IPR001356 | |
| Domain | PTB | 3.74e-03 | 40 | 146 | 3 | SM00462 | |
| Domain | PTB/PI_dom | 4.01e-03 | 41 | 146 | 3 | IPR006020 | |
| Domain | Link_dom | 4.47e-03 | 13 | 146 | 2 | IPR000538 | |
| Domain | Xlink | 4.47e-03 | 13 | 146 | 2 | PF00193 | |
| Domain | LINK_2 | 4.47e-03 | 13 | 146 | 2 | PS50963 | |
| Domain | LINK | 4.47e-03 | 13 | 146 | 2 | SM00445 | |
| Domain | LINK_1 | 4.47e-03 | 13 | 146 | 2 | PS01241 | |
| Domain | UBQ | 4.59e-03 | 43 | 146 | 3 | SM00213 | |
| Domain | SAM | 5.03e-03 | 88 | 146 | 4 | SM00454 | |
| Domain | ubiquitin | 5.90e-03 | 47 | 146 | 3 | PF00240 | |
| Domain | - | 5.96e-03 | 15 | 146 | 2 | 3.30.70.960 | |
| Domain | Glyco_hormone_CN | 5.96e-03 | 15 | 146 | 2 | IPR006208 | |
| Domain | Cys_knot | 5.96e-03 | 15 | 146 | 2 | PF00007 | |
| Domain | Znf_FYVE_PHD | 5.99e-03 | 147 | 146 | 5 | IPR011011 | |
| Domain | ZnF_C3H1 | 6.26e-03 | 48 | 146 | 3 | SM00356 | |
| Domain | PH | 6.30e-03 | 278 | 146 | 7 | SM00233 | |
| Domain | PH_DOMAIN | 6.42e-03 | 279 | 146 | 7 | PS50003 | |
| Domain | PH_domain | 6.54e-03 | 280 | 146 | 7 | IPR001849 | |
| Domain | SAM_DOMAIN | 6.58e-03 | 95 | 146 | 4 | PS50105 | |
| Domain | zf-CCCH | 6.63e-03 | 49 | 146 | 3 | PF00642 | |
| Domain | WH2 | 6.78e-03 | 16 | 146 | 2 | PF02205 | |
| Domain | SAM | 7.08e-03 | 97 | 146 | 4 | IPR001660 | |
| Pathway | REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC | 1.90e-11 | 16 | 113 | 7 | M27410 | |
| Pathway | REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS | 3.21e-11 | 17 | 113 | 7 | M27412 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 1.87e-10 | 21 | 113 | 7 | MM15706 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 3.89e-10 | 23 | 113 | 7 | M556 | |
| Pathway | REACTOME_DECTIN_2_FAMILY | 1.02e-09 | 26 | 113 | 7 | M27483 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 6.58e-08 | 68 | 113 | 8 | M27303 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 2.14e-07 | 143 | 113 | 10 | M27275 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 4.80e-07 | 60 | 113 | 7 | MM15636 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 6.03e-07 | 62 | 113 | 7 | M546 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 2.58e-06 | 109 | 113 | 8 | MM15164 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 2.95e-06 | 111 | 113 | 8 | M27416 | |
| Pathway | REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS | 1.65e-05 | 140 | 113 | 8 | M27484 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | 3.22e-05 | 250 | 113 | 10 | M27554 | |
| Pathway | PID_BETA_CATENIN_NUC_PATHWAY | 4.51e-04 | 80 | 113 | 5 | M223 | |
| Pubmed | BCL9L ATXN7L1 NACA BCORL1 C15orf39 E2F1 CC2D1A R3HDM2 PROSER1 NUP214 POGZ LHX8 BCL9 SRCAP UBN2 CREBBP CIC PHF21A PRDM2 IGF2BP1 NOL4L MIDN ZFHX4 UBAP2L PRRC2C ARID2 ZMIZ2 EIF4G1 SEC16A SUGP1 KDM2B HELZ RCOR3 ZFHX3 ZNF319 SAP130 CNOT3 SYMPK | 1.76e-19 | 1429 | 153 | 38 | 35140242 | |
| Pubmed | CASC3 SFPQ NYAP2 CTTNBP2 PRR36 KIF21A KSR2 SH3BP1 ANKS1B NFASC CHD4 SEC31A HUWE1 PPFIA3 CCDC6 BCL9 UBN2 SNAP91 ABI2 UBAP2L PRRC2C EIF4G1 SEC16A NAV1 PLEKHA5 SCRIB BSN AGRN PHLDB2 | 2.56e-16 | 963 | 153 | 29 | 28671696 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | BCL9L DTL BCORL1 C15orf39 PROSER1 NUP214 POGZ BCL9 UBN2 CREBBP PHF21A PRDM2 ZFHX4 ARID2 ZMIZ2 SEC16A KDM2B ZFHX3 MED12 | 1.78e-15 | 351 | 153 | 19 | 38297188 |
| Pubmed | BCORL1 UBQLN4 C15orf39 CHD4 NUP214 POGZ HUWE1 CIC PHF21A PRDM2 NOL4L ZFHX4 ZMIZ2 SEC16A NAV1 KDM2B PLEKHA5 RCOR3 ZFHX3 MED12 | 3.23e-15 | 418 | 153 | 20 | 34709266 | |
| Pubmed | Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux. | 4.91e-15 | 18 | 153 | 8 | 18834073 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | SFSWAP NELFA ZC3H13 CHD4 NUP214 POGZ HUWE1 CCDC6 BCL9 REXO1 CIC PRDM2 SMTN SCAF1 NOL4L UBAP2L EIF4G1 SEC16A KDM2B HELZ RIPOR1 SCRIB CNOT3 PHLDB2 SYMPK | 7.61e-15 | 774 | 153 | 25 | 15302935 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | PABIR1 CASC3 DLG5 ABL1 SH3RF1 MAP1B DTL C19orf47 CC2D1A CCDC6 RAB11FIP1 CIC KSR1 MLXIPL RBSN PIK3C3 PRRC2C EIF4G1 SEC16A NAV1 HELZ PLEKHA5 SCRIB PHLDB2 KIF1C | 8.29e-14 | 861 | 153 | 25 | 36931259 |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | DLG5 SH3RF1 DTL BCORL1 TBC1D2B C19orf47 C15orf39 HUWE1 CCDC6 SRCAP UBN2 CREBBP CIC PRRC2C ARID2 SEC16A NAV1 KDM2B HELZ BSN CNOT3 | 1.91e-13 | 588 | 153 | 21 | 38580884 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ABL1 SH3RF1 SPEG KSR2 C19orf47 C15orf39 CC2D1A NUP214 HUWE1 KDM6B BCL9 SRCAP REXO1 CIC HIVEP3 SCAF1 ZMIZ2 EIF4G1 SEC16A NAV1 RIPOR1 ULK1 SLC45A1 AGRN MED12 SYMPK | 2.98e-12 | 1105 | 153 | 26 | 35748872 |
| Pubmed | MAP1B PTPN23 CC2D1A POGZ HUWE1 SRCAP UBN2 CREBBP UBAP2L PRRC2C ARID2 SEC16A KDM2B PLEKHA5 SCRIB SAP130 MED12 SYMPK | 4.58e-11 | 549 | 153 | 18 | 38280479 | |
| Pubmed | SFPQ WIPF1 NELFA BCORL1 C15orf39 CC2D1A CHD4 POGZ BCL9 UBN2 CREBBP CIC PHF21A PRDM2 IGF2BP1 NOL4L PRRC2C ARID2 ZMIZ2 SUGP1 ZBTB3 SAP130 MED12 RAD23B | 1.11e-10 | 1103 | 153 | 24 | 34189442 | |
| Pubmed | SFSWAP ARHGAP10 ATXN7L1 CHD4 POGZ PPFIA3 RAB11FIP1 SRCAP PLEKHN1 CREBBP PDHX PHF21A SCAF1 KSR1 ZFHX4 ARID2 SEC16A JAZF1 HELZ RCOR3 ZFHX3 SCRIB SAP130 PHLDB2 | 1.41e-10 | 1116 | 153 | 24 | 31753913 | |
| Pubmed | BCL9L NELFA CHD4 BCL9 UBN2 CREBBP CIC PHF21A SUGP1 KDM2B RCOR3 SAP130 MED12 | 2.32e-10 | 268 | 153 | 13 | 33640491 | |
| Pubmed | 7.20e-10 | 101 | 153 | 9 | 26949739 | ||
| Pubmed | NELFA ZC3H13 DTL CC2D1A HUWE1 CCDC6 RAB11FIP1 RBSN IGF2BP1 UBAP2L EIF4G1 SEC16A PLEKHA5 SCRIB PHLDB2 KIF1C | 9.00e-10 | 503 | 153 | 16 | 16964243 | |
| Pubmed | BCL9L SFPQ PODXL NACA PTPN23 CC2D1A CHD4 NUP214 SEC31A MUC13 PPFIA3 RAB11FIP1 CREBBP ARHGEF15 SCMH1 EIF4G1 SEC16A KDM2B RIPOR1 | 1.06e-09 | 754 | 153 | 19 | 35906200 | |
| Pubmed | Polymorphism of human mucin genes in chest disease: possible significance of MUC2. | 1.79e-09 | 5 | 153 | 4 | 11062147 | |
| Pubmed | 1.79e-09 | 5 | 153 | 4 | 12507512 | ||
| Pubmed | 1.79e-09 | 5 | 153 | 4 | 17058067 | ||
| Pubmed | 5.36e-09 | 6 | 153 | 4 | 19110483 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | SFPQ SFSWAP MAP1B ZC3H13 BCORL1 CHD4 NUP214 POGZ UBN2 CIC IGF2BP1 SNAP91 UBAP2L PRRC2C ARID2 EIF4G1 SEC16A SUGP1 SAP130 SYMPK | 8.52e-09 | 954 | 153 | 20 | 36373674 |
| Pubmed | BCL9L CTTNBP2 SH3RF1 NELFA R3HDM2 CCDC6 RAB11FIP1 KSR1 SEC16A NAV1 HELZ PLEKHA5 PHLDB2 KIF1C | 1.26e-08 | 446 | 153 | 14 | 24255178 | |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | DLG5 NACA NUP214 MUC13 UBAP2L PRRC2C EIF4G1 SEC16A SUGP1 PLEKHA5 SCRIB | 2.06e-08 | 256 | 153 | 11 | 33397691 |
| Pubmed | 2.67e-08 | 152 | 153 | 9 | 38360978 | ||
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | RBL2 BCORL1 C15orf39 POGZ CREBBP PHF21A PRDM2 ZFHX4 ARID2 ZMIZ2 SEC16A JAZF1 KDM2B | 2.68e-08 | 398 | 153 | 13 | 35016035 |
| Pubmed | SFPQ SFSWAP MAP1B ZC3H13 UBQLN4 SEC31A IGF2BP1 UBAP2L PRRC2C SEC16A SCRIB SAP130 RAD23B | 2.76e-08 | 399 | 153 | 13 | 35987950 | |
| Pubmed | BCL9L CASC3 ABL1 CHD4 HUWE1 CREBBP PRRC2C EIF4G1 SEC16A NAV1 SCRIB NEURL1B | 3.12e-08 | 332 | 153 | 12 | 37433992 | |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | PABIR1 CASC3 TBC1D2B C15orf39 CC2D1A POGZ SEC31A CCDC6 RAB11FIP1 MAP3K1 KSR1 MLXIPL IGF2BP1 UBAP2L SEC16A SUGP1 PLEKHA5 RIPOR1 MED12 CNOT3 | 3.43e-08 | 1038 | 153 | 20 | 26673895 |
| Pubmed | SPEG R3HDM2 NUP214 POGZ MEGF9 UBAP2L PRRC2C SEC16A NAV1 RIPOR1 ULK1 SCRIB ZNF319 | 3.48e-08 | 407 | 153 | 13 | 12693553 | |
| Pubmed | SFPQ SH3RF1 WIPF1 PTPN23 NUP214 POGZ SEC31A CREBBP CIC ARID2 NAV1 HELZ PLEKHA5 SOS2 | 3.67e-08 | 486 | 153 | 14 | 20936779 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | MAP1B ARHGAP10 RBL2 POU2F2 CHD4 POGZ HUWE1 CREBBP CIC PHF21A ZFHX4 ABI2 PRRC2C EIF4G1 NKX6-1 SCRIB SAP130 SYMPK | 4.87e-08 | 857 | 153 | 18 | 25609649 |
| Pubmed | BCL9L CASC3 SFSWAP NACA BCORL1 C15orf39 PROSER1 BCL9 UBN2 CREBBP CIC SMTN RAD23B | 5.76e-08 | 425 | 153 | 13 | 24999758 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | SFPQ SFSWAP ZC3H13 BCORL1 UBQLN4 CHD4 NUP214 POGZ SRCAP UBN2 CIC PHF21A PRDM2 SCAF1 MLXIPL JAZF1 KDM2B RCOR3 ZNF319 SAP130 SYMPK RAD23B | 6.05e-08 | 1294 | 153 | 22 | 30804502 |
| Pubmed | 8.35e-08 | 3 | 153 | 3 | 30236127 | ||
| Pubmed | 8.35e-08 | 3 | 153 | 3 | 19718741 | ||
| Pubmed | 8.35e-08 | 3 | 153 | 3 | 23464473 | ||
| Pubmed | MKRN4P CUX2 SH3RF1 POU2F2 E2F1 CHD4 POGZ IRX3 LHX8 CREBBP CIC PHF21A RBSN ZMIZ2 ZFHX3 ZBTB3 | 1.08e-07 | 709 | 153 | 16 | 22988430 | |
| Pubmed | 1.33e-07 | 242 | 153 | 10 | 34011540 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | SFPQ MAP1B NACA PTPN23 CC2D1A CHD4 NUP214 SRCAP CIC PHF21A IGF2BP1 UBAP2L PRRC2C ARID2 SEC16A SUGP1 HELZ SCRIB | 1.75e-07 | 934 | 153 | 18 | 33916271 |
| Pubmed | 3.33e-07 | 4 | 153 | 3 | 25638393 | ||
| Pubmed | Expression of MUC1, MUC2, MUC5AC and MUC5B in mucinous lesions of the breast. | 3.33e-07 | 4 | 153 | 3 | 22269464 | |
| Pubmed | 3.33e-07 | 4 | 153 | 3 | 23807779 | ||
| Pubmed | 3.33e-07 | 4 | 153 | 3 | 21647207 | ||
| Pubmed | 3.33e-07 | 4 | 153 | 3 | 17471237 | ||
| Pubmed | 3.33e-07 | 4 | 153 | 3 | 14984930 | ||
| Pubmed | Effects of the Helicobacter pylori Virulence Factor CagA and Ammonium Ion on Mucins in AGS Cells. | 3.33e-07 | 4 | 153 | 3 | 29869461 | |
| Pubmed | 3.33e-07 | 4 | 153 | 3 | 12676567 | ||
| Pubmed | 6.26e-07 | 69 | 153 | 6 | 32238831 | ||
| Pubmed | DLG5 NYAP2 KIF21A NACA TBC1D2B NFASC POGZ KDM6B PHF21A KDM2B PLEKHA5 MAML2 BSN | 6.96e-07 | 529 | 153 | 13 | 14621295 | |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | SFPQ MAP1B NELFA UBN2 CREBBP PHF21A SMTN UBAP2L EIF4G1 SEC16A SUGP1 SYMPK | 7.05e-07 | 444 | 153 | 12 | 34795231 |
| Pubmed | 8.29e-07 | 5 | 153 | 3 | 12135769 | ||
| Pubmed | Differential expression of MUC genes in endometrial and cervical tissues and tumors. | 8.29e-07 | 5 | 153 | 3 | 16188033 | |
| Pubmed | MUC1, MUC2, MUC4, MUC5AC and MUC6 expression in the progression of prostate cancer. | 8.29e-07 | 5 | 153 | 3 | 16475027 | |
| Pubmed | LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells. | RBL2 PTPN23 HUWE1 PPFIA3 CCDC6 PDHX IGF2BP1 PRRC2C SEC16A HELZ PLEKHA5 AGRN PHLDB2 SYMPK | 9.98e-07 | 639 | 153 | 14 | 23443559 |
| Pubmed | SFPQ MAP1B ZC3H13 CHD4 NUP214 POGZ HUWE1 UBAP2L PRRC2C EIF4G1 SEC16A HELZ MED12 SYMPK | 1.29e-06 | 653 | 153 | 14 | 22586326 | |
| Pubmed | DLG5 NACA PTPN23 SEC31A CCDC6 CIC SMTN ARID2 SEC16A PLEKHA5 SAP130 MED12 | 1.33e-06 | 472 | 153 | 12 | 38943005 | |
| Pubmed | 1.65e-06 | 20 | 153 | 4 | 30596474 | ||
| Pubmed | 1.86e-06 | 251 | 153 | 9 | 31076518 | ||
| Pubmed | CTTNBP2 SH3RF1 PTPN23 UBN2 REXO1 ARHGEF15 HIVEP3 ARID2 FLRT2 MED12 CNOT3 KIF1C | 2.09e-06 | 493 | 153 | 12 | 15368895 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | SFPQ MAP1B KIF21A NACA PTPN23 CHD4 NUP214 POGZ SEC31A HUWE1 SRCAP CREBBP SMTN EIF4G1 SEC16A PLEKHA5 SCRIB AGRN MED12 PHLDB2 | 2.22e-06 | 1353 | 153 | 20 | 29467282 |
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | SFPQ MAP1B KIF21A PTPN23 NUP214 RBSN IGF2BP1 UBAP2L VCAN SEC16A NAV1 SCRIB | 2.32e-06 | 498 | 153 | 12 | 36634849 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | RAD52 CASC3 MAP1B ARHGAP10 ATXN7L1 KSR2 DAB1 NFASC HUWE1 UBN2 SSPOP CREBBP HIVEP3 PIK3C3 UBAP2L NAV1 RCOR3 RIPOR1 ZFHX3 SAP130 SOS2 | 2.53e-06 | 1489 | 153 | 21 | 28611215 |
| Pubmed | MKRN4P CUX2 ZC3H13 POU2F2 E2F1 POGZ LHX8 SRCAP CIC PHF21A HIVEP3 ARID2 ZMIZ2 JAZF1 ZFHX3 | 3.11e-06 | 808 | 153 | 15 | 20412781 | |
| Pubmed | DLG5 SH3RF1 MAP1B PTPN23 CC2D1A NUP214 SEC31A UBAP2L PRRC2C EIF4G1 SEC16A PLEKHA5 SCRIB MED12 | 3.28e-06 | 708 | 153 | 14 | 39231216 | |
| Pubmed | 3.39e-06 | 52 | 153 | 5 | 26265008 | ||
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | CUX2 NUP214 BCL9 CIC MAP3K1 ARID2 ZMIZ2 MAML2 BSN SAP130 SOS2 | 3.52e-06 | 430 | 153 | 11 | 35044719 |
| Pubmed | 3.73e-06 | 53 | 153 | 5 | 34026424 | ||
| Pubmed | ZMYM3 regulates BRCA1 localization at damaged chromatin to promote DNA repair. | 4.83e-06 | 150 | 153 | 7 | 28242625 | |
| Pubmed | DLG5 MAP1B BCORL1 HUWE1 SRCAP UBN2 CREBBP UBAP2L SEC16A NAV1 SCRIB MED12 RAD23B | 6.09e-06 | 645 | 153 | 13 | 25281560 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | DLG5 SFPQ SFSWAP MAP1B ZC3H13 CHD4 POGZ SEC31A SRCAP IGF2BP1 ARID2 VCAN EIF4G1 SUGP1 AGRN MED12 SYMPK | 6.16e-06 | 1082 | 153 | 17 | 38697112 |
| Pubmed | SFPQ ZC3H13 DTL PTPN23 SEC31A HUWE1 SRCAP UBN2 PRDM2 SMTN NOL4L CGB2 UBAP2L VCAN SEC16A RCOR3 AGRN | 6.31e-06 | 1084 | 153 | 17 | 11544199 | |
| Pubmed | SFPQ MAP1B ZC3H13 NACA HUWE1 CCDC6 PDHX IGF2BP1 UBAP2L PRRC2C EIF4G1 SEC16A | 6.48e-06 | 551 | 153 | 12 | 34728620 | |
| Pubmed | 6.79e-06 | 222 | 153 | 8 | 37071664 | ||
| Pubmed | New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules. | CASC3 SFPQ ZC3H13 NUP214 IGF2BP1 UBAP2L PRRC2C EIF4G1 NAV1 HELZ MED12 | 6.94e-06 | 462 | 153 | 11 | 31138677 |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | MAP1B NACA C19orf47 CHD4 PDHX MAP3K1 IGF2BP1 PIK3C3 UBAP2L PRRC2C ARID2 EIF4G1 SAP130 MED12 | 7.24e-06 | 759 | 153 | 14 | 35915203 |
| Pubmed | 7.49e-06 | 225 | 153 | 8 | 12168954 | ||
| Pubmed | 8.23e-06 | 107 | 153 | 6 | 30995489 | ||
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | DLG5 MAP1B PODXL KIF21A NACA PTPN23 MUC5B CHD4 NUP214 SEC31A HUWE1 UBAP2L EIF4G1 SEC16A SCRIB MUC7 PHLDB2 SYMPK RAD23B | 9.73e-06 | 1367 | 153 | 19 | 32687490 |
| Pubmed | BCL9L CASC3 DLG5 SFSWAP ARHGAP10 NACA RAB11FIP1 UBN2 CIC SCAF1 ABI2 ARID2 EIF4G1 KDM2B HELZ ZFHX3 AGRN MED12 CNOT3 RAD23B | 9.92e-06 | 1497 | 153 | 20 | 31527615 | |
| Pubmed | BCL9L SFPQ NYAP2 MAP1B NACA ANKS1B HUWE1 PPFIA3 PDHX RBSN ABI2 UBAP2L PRRC2C NAV1 HELZ BSN CNOT3 | 1.20e-05 | 1139 | 153 | 17 | 36417873 | |
| Pubmed | 1.43e-05 | 246 | 153 | 8 | 15345747 | ||
| Pubmed | 1.51e-05 | 34 | 153 | 4 | 30894540 | ||
| Pubmed | RBL2 KIF21A PLA2G3 UBQLN4 ANKS1B CHD4 POGZ SEC31A HUWE1 CCDC6 KDM6B CREBBP MEGF9 EIF4G1 SCRIB CNOT3 SOS2 RAD23B | 1.53e-05 | 1285 | 153 | 18 | 35914814 | |
| Pubmed | UBQLN4 TNS2 R3HDM2 SSPOP CIC SCAF1 UBAP2L SCMH1 PLEKHA5 RTL8C AGRN RAD23B | 1.73e-05 | 608 | 153 | 12 | 16713569 | |
| Pubmed | SFPQ CTTNBP2 MAP1B PRR36 ANKS1B NFASC PPFIA3 PDHX MLXIPL SNAP91 UBAP2L PRRC2C VCAN EIF4G1 SEC16A NAV1 PLEKHA5 SCRIB BSN | 1.84e-05 | 1431 | 153 | 19 | 37142655 | |
| Pubmed | A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. | PODXL NELFA SEC31A MUC13 RAB11FIP1 PLEKHN1 KSR1 RBSN UBAP2L NAV1 PLEKHA5 SCRIB AGRN | 1.92e-05 | 719 | 153 | 13 | 35337019 |
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 7513696 | ||
| Pubmed | Kinase suppressor of Ras 2 (KSR2) regulates tumor cell transformation via AMPK. | 1.92e-05 | 2 | 153 | 2 | 22801368 | |
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 37146737 | ||
| Pubmed | MUC5AC and MUC5B Mucins Are Decreased in Cystic Fibrosis Airway Secretions. | 1.92e-05 | 2 | 153 | 2 | 14988081 | |
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 15563276 | ||
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 17621824 | ||
| Pubmed | MUC4 and MUC5AC are highly specific tumour-associated mucins in biliary tract cancer. | 1.92e-05 | 2 | 153 | 2 | 18475301 | |
| Pubmed | Anti-HIV-1 activity of salivary MUC5B and MUC7 mucins from HIV patients with different CD4 counts. | 1.92e-05 | 2 | 153 | 2 | 20946627 | |
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 22220206 | ||
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 12459324 | ||
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 24317696 | ||
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 22391959 | ||
| Pubmed | Mucins MUC5AC and MUC5B Are Variably Packaged in the Same and in Separate Secretory Granules. | 1.92e-05 | 2 | 153 | 2 | 35776514 | |
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 24327612 | ||
| Interaction | EGR2 interactions | BCL9L BCORL1 C15orf39 PROSER1 POGZ BCL9 UBN2 CREBBP PHF21A ZFHX4 ARID2 ZMIZ2 SEC16A KDM2B ZFHX3 | 3.35e-12 | 171 | 152 | 15 | int:EGR2 |
| Interaction | YWHAH interactions | PABIR1 CASC3 DLG5 ABL1 SH3RF1 SFSWAP SPEG ZC3H13 DTL KSR2 C19orf47 TNS2 CC2D1A R3HDM2 HUWE1 CCDC6 RAB11FIP1 CREBBP CIC PYHIN1 KSR1 MLXIPL RBSN ABI2 PIK3C3 PRRC2C EIF4G1 SEC16A NAV1 PLEKHA5 SCRIB PHLDB2 KIF1C | 7.04e-12 | 1102 | 152 | 33 | int:YWHAH |
| Interaction | CRX interactions | BCL9L BCORL1 C15orf39 TNS2 PROSER1 POGZ BCL9 UBN2 CREBBP ZFHX4 ABI2 ARID2 ZMIZ2 KDM2B ZFHX3 MED12 | 9.41e-11 | 254 | 152 | 16 | int:CRX |
| Interaction | SOX6 interactions | C15orf39 PROSER1 UBN2 CIC IGF2BP1 ZFHX4 PRRC2C ZMIZ2 KDM2B RCOR3 ZFHX3 SAP130 | 2.60e-09 | 157 | 152 | 12 | int:SOX6 |
| Interaction | YWHAG interactions | PABIR1 CASC3 DLG5 ABL1 SH3RF1 SPEG ZC3H13 DTL KSR2 C19orf47 TNS2 R3HDM2 HUWE1 CCDC6 RAB11FIP1 CIC MAP3K1 PYHIN1 KSR1 MLXIPL PIK3C3 PRRC2C EIF4G1 SEC16A NAV1 HELZ PLEKHA5 ULK1 SCRIB PHLDB2 KIF1C | 3.32e-09 | 1248 | 152 | 31 | int:YWHAG |
| Interaction | SP7 interactions | BCL9L C15orf39 PROSER1 POGZ BCL9 CREBBP CIC IGF2BP1 ZFHX4 ARID2 ZMIZ2 SUGP1 KDM2B RCOR3 SAP130 | 1.06e-08 | 304 | 152 | 15 | int:SP7 |
| Interaction | HNF1B interactions | OXER1 PROSER1 POGZ BCL9 UBN2 CREBBP CIC ZFHX4 ARID2 KDM2B ZFHX3 SAP130 | 2.24e-08 | 190 | 152 | 12 | int:HNF1B |
| Interaction | AR interactions | BCL9L SFPQ ABL1 NELFA POU2F2 E2F1 CHD4 HUWE1 RAB11FIP1 BCL9 SRCAP UBN2 CREBBP CIC PHF21A UBAP2L ARID2 ZMIZ2 SEC16A SUGP1 KDM2B RCOR3 ZFHX3 SAP130 MED12 SYMPK | 2.58e-08 | 992 | 152 | 26 | int:AR |
| Interaction | MEX3A interactions | BCL9L CASC3 ABL1 R3HDM2 CHD4 HUWE1 CREBBP IGF2BP1 UBAP2L PRRC2C EIF4G1 SEC16A NAV1 SCRIB NEURL1B CNOT3 | 3.59e-08 | 384 | 152 | 16 | int:MEX3A |
| Interaction | PAX9 interactions | BCL9L C15orf39 PROSER1 BCL9 CIC ZFHX4 ZMIZ2 KDM2B ZFHX3 SAP130 | 5.44e-08 | 130 | 152 | 10 | int:PAX9 |
| Interaction | YWHAQ interactions | PABIR1 DLG5 ABL1 SH3RF1 ARHGAP10 SPEG ZC3H13 DTL KSR2 UBQLN4 C19orf47 E2F1 R3HDM2 CCDC6 RAB11FIP1 CIC MAP3K1 KSR1 MLXIPL PIK3C3 EIF4G1 NAV1 PLEKHA5 RCOR3 SCRIB PHLDB2 KIF1C | 7.23e-08 | 1118 | 152 | 27 | int:YWHAQ |
| Interaction | CTBP1 interactions | SFPQ RBL2 BCORL1 C15orf39 CHD4 SEC31A CREBBP CIC PRDM2 NOL4L SEC16A KDM2B HELZ RCOR3 MAML2 DCAF11 | 7.74e-08 | 406 | 152 | 16 | int:CTBP1 |
| Interaction | TLX1 interactions | POGZ BCL9 UBN2 CREBBP CIC IGF2BP1 ZFHX4 KDM2B RCOR3 ZFHX3 SAP130 | 9.28e-08 | 175 | 152 | 11 | int:TLX1 |
| Interaction | YWHAZ interactions | PABIR1 RAD52 DLG5 SFPQ ABL1 SH3RF1 RASGRF2 NELFA SPEG DTL KSR2 R3HDM2 HUWE1 PPFIA3 CCDC6 RAB11FIP1 CIC MAP3K1 KSR1 MLXIPL ABI2 PIK3C3 NAV1 PLEKHA5 ULK1 SCRIB PHLDB2 GP1BA KIF1C | 1.64e-07 | 1319 | 152 | 29 | int:YWHAZ |
| Interaction | KLF3 interactions | BCORL1 POGZ LHX8 UBN2 CIC PHF21A PRDM2 ARID2 KDM2B RCOR3 ZFHX3 SAP130 | 1.66e-07 | 228 | 152 | 12 | int:KLF3 |
| Interaction | SOX7 interactions | 1.93e-07 | 82 | 152 | 8 | int:SOX7 | |
| Interaction | LHX6 interactions | 2.63e-07 | 58 | 152 | 7 | int:LHX6 | |
| Interaction | GSC interactions | 3.07e-07 | 87 | 152 | 8 | int:GSC | |
| Interaction | KLF15 interactions | BCORL1 POGZ BCL9 CREBBP CIC IGF2BP1 NOL4L PRRC2C ARID2 SEC16A KDM2B ZNF319 SAP130 | 3.19e-07 | 290 | 152 | 13 | int:KLF15 |
| Interaction | PHF21A interactions | BCORL1 C15orf39 NUP214 HUWE1 CIC PHF21A ZFHX4 ZMIZ2 SEC16A NAV1 KDM2B PLEKHA5 RCOR3 ZFHX3 | 3.44e-07 | 343 | 152 | 14 | int:PHF21A |
| Interaction | FEV interactions | C15orf39 POGZ BCL9 UBN2 CREBBP CIC PHF21A ZFHX4 ARID2 KDM2B ZFHX3 | 4.15e-07 | 203 | 152 | 11 | int:FEV |
| Interaction | SOX5 interactions | PROSER1 POGZ CIC IGF2BP1 ZFHX4 PRRC2C KDM2B RCOR3 ZFHX3 SAP130 | 4.29e-07 | 162 | 152 | 10 | int:SOX5 |
| Interaction | TOP3B interactions | ABL1 SH3RF1 SPEG KSR2 C19orf47 C15orf39 CC2D1A R3HDM2 NUP214 HUWE1 KDM6B BCL9 SRCAP REXO1 CIC HIVEP3 SCAF1 IGF2BP1 UBAP2L ZMIZ2 EIF4G1 SEC16A NAV1 HELZ RIPOR1 ULK1 SLC45A1 AGRN MED12 SYMPK | 4.76e-07 | 1470 | 152 | 30 | int:TOP3B |
| Interaction | KDM1A interactions | DLG5 BCORL1 UBQLN4 C15orf39 E2F1 CHD4 NUP214 POGZ HUWE1 CIC PHF21A PRDM2 NOL4L ZFHX4 SEC16A NAV1 KDM2B PLEKHA5 RCOR3 ZFHX3 MED12 CNOT3 SYMPK | 6.21e-07 | 941 | 152 | 23 | int:KDM1A |
| Interaction | YWHAE interactions | PABIR1 RAD52 DLG5 SFPQ ABL1 SH3RF1 MAP1B DTL KSR2 TNS2 R3HDM2 HUWE1 CCDC6 RAB11FIP1 CIC MAP3K1 KSR1 IGF2BP1 MIDN ABI2 NAV1 PLEKHA5 ULK1 SAP130 AGRN PHLDB2 KIF1C | 7.29e-07 | 1256 | 152 | 27 | int:YWHAE |
| Interaction | PAX6 interactions | POGZ CCDC6 BCL9 SRCAP UBN2 CREBBP CIC PHF21A ZFHX4 ARID2 KDM2B RCOR3 ZFHX3 SAP130 | 7.49e-07 | 366 | 152 | 14 | int:PAX6 |
| Interaction | FOXQ1 interactions | 1.25e-06 | 141 | 152 | 9 | int:FOXQ1 | |
| Interaction | ALG13 interactions | C15orf39 R3HDM2 BCL9 IGF2BP1 UBAP2L PRRC2C SEC16A KDM2B HELZ RCOR3 | 1.31e-06 | 183 | 152 | 10 | int:ALG13 |
| Interaction | KLF8 interactions | BCORL1 POGZ UBN2 CREBBP CIC PHF21A PRDM2 PRRC2C ARID2 EIF4G1 SEC16A KDM2B SAP130 | 1.32e-06 | 329 | 152 | 13 | int:KLF8 |
| Interaction | DDB1 interactions | SFPQ ABL1 MAP1B ZC3H13 DTL E2F1 HUWE1 BCL9 CREBBP CIC ARHGEF15 PHF21A MAP3K1 PYHIN1 MLXIPL MIDN DCAF11 SAP130 MED12 | 1.33e-06 | 697 | 152 | 19 | int:DDB1 |
| Interaction | LHX3 interactions | 1.45e-06 | 185 | 152 | 10 | int:LHX3 | |
| Interaction | TLX3 interactions | BCL9L C15orf39 PROSER1 POGZ BCL9 CIC ZFHX4 ARID2 ZMIZ2 KDM2B RCOR3 ZFHX3 | 2.21e-06 | 291 | 152 | 12 | int:TLX3 |
| Interaction | YWHAB interactions | PABIR1 CASC3 DLG5 ABL1 SH3RF1 NELFA SPEG DTL KSR2 TNS2 R3HDM2 CCDC6 RAB11FIP1 CIC KSR1 ABI2 EIF4G1 NAV1 PLEKHA5 SCRIB SAP130 PHLDB2 KIF1C | 2.22e-06 | 1014 | 152 | 23 | int:YWHAB |
| Interaction | EYA4 interactions | SFPQ MAPK1IP1L C15orf39 R3HDM2 PROSER1 BCL9 UBN2 CREBBP CIC ZMIZ2 HELZ | 2.43e-06 | 243 | 152 | 11 | int:EYA4 |
| Interaction | TBXT interactions | 2.78e-06 | 116 | 152 | 8 | int:TBXT | |
| Interaction | ASF1A interactions | NELFA ZC3H13 BCORL1 E2F1 POGZ SRCAP UBN2 PRDM2 ARID2 SUGP1 SAP130 | 3.07e-06 | 249 | 152 | 11 | int:ASF1A |
| Interaction | CNOT3 interactions | MAP1B R3HDM2 HUWE1 CCDC6 CREBBP RBSN UBAP2L PRRC2C HELZ CNOT3 | 3.97e-06 | 207 | 152 | 10 | int:CNOT3 |
| Interaction | DYRK1A interactions | DLG5 SFPQ MAP1B RBL2 TNS2 NUP214 HUWE1 CREBBP CIC MAP3K1 MEGF9 EIF4G1 SEC16A PLEKHA5 SCRIB CNOT3 | 4.46e-06 | 552 | 152 | 16 | int:DYRK1A |
| Interaction | YTHDF2 interactions | CASC3 SFPQ PTPN23 R3HDM2 HUWE1 CREBBP CIC IGF2BP1 UBAP2L PRRC2C HELZ CNOT3 | 4.52e-06 | 312 | 152 | 12 | int:YTHDF2 |
| Interaction | PAX7 interactions | 4.58e-06 | 124 | 152 | 8 | int:PAX7 | |
| Interaction | EWSR1 interactions | BCL9L CASC3 SFPQ ABL1 SFSWAP MAPK1IP1L NACA BCORL1 C15orf39 PROSER1 CHD4 BCL9 UBN2 CREBBP CIC PDHX SMTN UBAP2L SCMH1 AGRN RAD23B | 4.61e-06 | 906 | 152 | 21 | int:EWSR1 |
| Interaction | TLE3 interactions | BCL9L BCORL1 C15orf39 PROSER1 BCL9 UBN2 CREBBP CIC ARID2 ZMIZ2 HELZ ZFHX3 SAP130 | 5.71e-06 | 376 | 152 | 13 | int:TLE3 |
| Interaction | BIN1 interactions | 6.14e-06 | 129 | 152 | 8 | int:BIN1 | |
| Interaction | R3HDM2 interactions | 6.14e-06 | 129 | 152 | 8 | int:R3HDM2 | |
| Interaction | MEX3B interactions | CASC3 CC2D1A R3HDM2 IGF2BP1 PIK3C3 UBAP2L PRRC2C SEC16A HELZ CNOT3 | 7.38e-06 | 222 | 152 | 10 | int:MEX3B |
| Interaction | SOX9 interactions | 8.80e-06 | 97 | 152 | 7 | int:SOX9 | |
| Interaction | LHX2 interactions | 1.06e-05 | 183 | 152 | 9 | int:LHX2 | |
| Interaction | PPIA interactions | RAD52 DLG5 SFPQ ABL1 MAP1B NACA PTPN23 SEC31A HUWE1 CCDC6 CIC SMTN MIDN ARID2 SEC16A PLEKHA5 SAP130 MED12 CNOT3 RAD23B | 1.21e-05 | 888 | 152 | 20 | int:PPIA |
| Interaction | CPEB1 interactions | 1.52e-05 | 146 | 152 | 8 | int:CPEB1 | |
| Interaction | EIF4ENIF1 interactions | C15orf39 R3HDM2 CREBBP PHF21A IGF2BP1 UBAP2L PRRC2C EIF4G1 SEC16A HELZ CNOT3 | 1.79e-05 | 300 | 152 | 11 | int:EIF4ENIF1 |
| Interaction | FOXL1 interactions | 1.84e-05 | 196 | 152 | 9 | int:FOXL1 | |
| Interaction | CEBPA interactions | SFPQ WIPF1 NELFA BCORL1 C15orf39 CC2D1A CHD4 POGZ BCL9 UBN2 CREBBP CIC PHF21A PRDM2 IGF2BP1 NOL4L PRRC2C ARID2 ZMIZ2 SUGP1 ZBTB3 SAP130 MED12 RAD23B | 2.04e-05 | 1245 | 152 | 24 | int:CEBPA |
| Interaction | GALNT14 interactions | 2.05e-05 | 22 | 152 | 4 | int:GALNT14 | |
| Interaction | GATA2 interactions | 2.07e-05 | 199 | 152 | 9 | int:GATA2 | |
| Interaction | TBR1 interactions | 2.39e-05 | 113 | 152 | 7 | int:TBR1 | |
| Interaction | ZCCHC2 interactions | 2.46e-05 | 23 | 152 | 4 | int:ZCCHC2 | |
| Interaction | TRRAP interactions | SFPQ PODXL RBL2 NACA E2F1 NUP214 MUC13 PPFIA3 RAB11FIP1 SRCAP CREBBP ARHGEF15 SCMH1 EIF4G1 JAZF1 RIPOR1 MED12 CNOT3 | 2.94e-05 | 790 | 152 | 18 | int:TRRAP |
| Interaction | SMG7 interactions | R3HDM2 CCDC6 BCL9 CREBBP UBAP2L SEC16A KDM2B HELZ RCOR3 DCAF11 CNOT3 | 3.14e-05 | 319 | 152 | 11 | int:SMG7 |
| Interaction | TDRD3 interactions | 3.41e-05 | 212 | 152 | 9 | int:TDRD3 | |
| Interaction | BMI1 interactions | CASC3 DLG5 ZC3H13 BCORL1 CHD4 SEC31A CREBBP IGF2BP1 UBAP2L SCMH1 PRRC2C EIF4G1 SUGP1 KDM2B HELZ MED12 | 3.95e-05 | 659 | 152 | 16 | int:BMI1 |
| Interaction | PRRC2A interactions | CASC3 SFPQ UBQLN4 R3HDM2 HUWE1 IGF2BP1 UBAP2L PRRC2C SEC16A HELZ CNOT3 RAD23B | 4.06e-05 | 389 | 152 | 12 | int:PRRC2A |
| Interaction | ZMYM2 interactions | 4.11e-05 | 271 | 152 | 10 | int:ZMYM2 | |
| Interaction | CEP85 interactions | 4.36e-05 | 169 | 152 | 8 | int:CEP85 | |
| Interaction | PHLPP1 interactions | DLG5 NACA NUP214 MUC13 UBAP2L PRRC2C EIF4G1 SEC16A SUGP1 PLEKHA5 SCRIB | 4.64e-05 | 333 | 152 | 11 | int:PHLPP1 |
| Interaction | MARF1 interactions | 5.33e-05 | 128 | 152 | 7 | int:MARF1 | |
| Interaction | TNRC6A interactions | DLG5 SFPQ R3HDM2 CCDC6 PHF21A UBAP2L SEC16A HELZ MED12 CNOT3 | 5.41e-05 | 280 | 152 | 10 | int:TNRC6A |
| Interaction | TEAD1 interactions | 5.81e-05 | 176 | 152 | 8 | int:TEAD1 | |
| Interaction | RAD51B interactions | 5.87e-05 | 55 | 152 | 5 | int:RAD51B | |
| Interaction | SMC5 interactions | SFPQ SFSWAP MAP1B ZC3H13 BCORL1 CHD4 NUP214 POGZ UBN2 CIC IGF2BP1 SNAP91 UBAP2L PRRC2C ARID2 EIF4G1 SEC16A SUGP1 SAP130 SYMPK | 6.49e-05 | 1000 | 152 | 20 | int:SMC5 |
| Interaction | ZFP36 interactions | 7.08e-05 | 181 | 152 | 8 | int:ZFP36 | |
| Interaction | CDC25B interactions | 7.13e-05 | 134 | 152 | 7 | int:CDC25B | |
| Interaction | PRRC2C interactions | SFPQ UBQLN4 R3HDM2 CHD4 IGF2BP1 UBAP2L PRRC2C SEC16A HELZ CNOT3 | 7.25e-05 | 290 | 152 | 10 | int:PRRC2C |
| Interaction | NUP43 interactions | BCL9L ZC3H13 NUP214 POGZ SRCAP UBN2 PHF21A PRDM2 SMTN SCAF1 PRRC2C ARID2 EIF4G1 ZFHX3 MED12 | 7.93e-05 | 625 | 152 | 15 | int:NUP43 |
| Interaction | HDAC1 interactions | SFPQ RBL2 UBQLN4 C15orf39 E2F1 CHD4 NUP214 CCDC6 CREBBP CIC PHF21A ZFHX4 ZMIZ2 NAV1 KDM2B PLEKHA5 RCOR3 ZFHX3 SAP130 MED12 SYMPK | 9.02e-05 | 1108 | 152 | 21 | int:HDAC1 |
| Interaction | RCOR1 interactions | BCORL1 C15orf39 CHD4 HUWE1 CIC PHF21A ZFHX4 SEC16A KDM2B PLEKHA5 RCOR3 ZFHX3 MED12 | 9.76e-05 | 494 | 152 | 13 | int:RCOR1 |
| Interaction | FAM120C interactions | 1.03e-04 | 191 | 152 | 8 | int:FAM120C | |
| Interaction | DAZL interactions | 1.17e-04 | 145 | 152 | 7 | int:DAZL | |
| Interaction | FOS interactions | 1.32e-04 | 312 | 152 | 10 | int:FOS | |
| Interaction | NR3C1 interactions | SFPQ NYAP2 BCORL1 MUC16 POU2F2 NUP214 POGZ PPFIA3 CCDC6 BCL9 CREBBP CIC PDHX ARID2 SUGP1 KDM2B RCOR3 BSN ZBTB3 | 1.39e-04 | 974 | 152 | 19 | int:NR3C1 |
| Interaction | LZTS2 interactions | DLG5 TBC1D2B R3HDM2 HUWE1 CCDC6 PLEKHN1 ABI2 SEC16A HELZ PLEKHA5 RCOR3 MED12 PHLDB2 | 1.39e-04 | 512 | 152 | 13 | int:LZTS2 |
| Interaction | HELZ interactions | C15orf39 R3HDM2 CREBBP IGF2BP1 UBAP2L PRRC2C SEC16A HELZ CNOT3 | 1.49e-04 | 257 | 152 | 9 | int:HELZ |
| Interaction | GCM1 interactions | 1.62e-04 | 68 | 152 | 5 | int:GCM1 | |
| Interaction | TDG interactions | 1.74e-04 | 69 | 152 | 5 | int:TDG | |
| Interaction | ETV4 interactions | 1.74e-04 | 69 | 152 | 5 | int:ETV4 | |
| Interaction | GIGYF2 interactions | 1.77e-04 | 263 | 152 | 9 | int:GIGYF2 | |
| Interaction | RBMS1 interactions | 1.79e-04 | 207 | 152 | 8 | int:RBMS1 | |
| Interaction | CPEB4 interactions | 1.84e-04 | 156 | 152 | 7 | int:CPEB4 | |
| Interaction | MKNK1 interactions | 1.86e-04 | 70 | 152 | 5 | int:MKNK1 | |
| Interaction | EN1 interactions | 1.87e-04 | 110 | 152 | 6 | int:EN1 | |
| Interaction | PAX8 interactions | 1.97e-04 | 111 | 152 | 6 | int:PAX8 | |
| Interaction | FHL2 interactions | SFPQ SH3RF1 E2F1 POGZ CREBBP PHF21A PRRC2C PLEKHA5 RCOR3 SAP130 CNOT3 | 2.14e-04 | 396 | 152 | 11 | int:FHL2 |
| Interaction | FMR1 interactions | CASC3 SFPQ MAP1B CHD4 BCL9 IGF2BP1 UBAP2L PRRC2C EIF4G1 SCRIB BSN ZBTB3 CNOT3 | 2.18e-04 | 536 | 152 | 13 | int:FMR1 |
| Interaction | YAP1 interactions | BCL9L SFPQ ABL1 CC2D1A CHD4 POGZ HUWE1 CCDC6 SRCAP UBN2 CREBBP UBAP2L PRRC2C ARID2 SEC16A KDM2B SCRIB SAP130 MED12 SYMPK | 2.20e-04 | 1095 | 152 | 20 | int:YAP1 |
| Interaction | ZFHX4 interactions | 2.27e-04 | 73 | 152 | 5 | int:ZFHX4 | |
| Interaction | ZC3H7A interactions | 2.32e-04 | 215 | 152 | 8 | int:ZC3H7A | |
| Interaction | SFN interactions | PABIR1 SFPQ ABL1 SH3RF1 MAP1B DTL RAB11FIP1 KSR1 PRRC2C EIF4G1 NAV1 PLEKHA5 SCRIB SAP130 PHLDB2 | 2.41e-04 | 692 | 152 | 15 | int:SFN |
| Interaction | HNF4A interactions | 2.47e-04 | 275 | 152 | 9 | int:HNF4A | |
| Interaction | LHX4 interactions | 2.70e-04 | 166 | 152 | 7 | int:LHX4 | |
| Interaction | SUPT5H interactions | WIPF1 NELFA TNS2 CHD4 UBN2 CIC PYHIN1 SCAF1 KDM2B RCOR3 ZBTB3 | 2.76e-04 | 408 | 152 | 11 | int:SUPT5H |
| Interaction | NANOG interactions | RAD52 MUC16 CHD4 POGZ HUWE1 IGF2BP1 SEC16A SUGP1 KDM2B SAP130 MED12 RAD23B | 2.96e-04 | 481 | 152 | 12 | int:NANOG |
| GeneFamily | CD molecules|Mucins | 1.16e-13 | 21 | 99 | 8 | 648 | |
| GeneFamily | Mitogen-activated protein kinase kinase kinases|RAF family | 2.94e-04 | 5 | 99 | 2 | 1157 | |
| GeneFamily | Sterile alpha motif domain containing | 1.39e-03 | 88 | 99 | 4 | 760 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | MAP1B SPEG KIF21A KSR2 TBC1D2B ANKS1B NFASC POU2F2 IRX3 UBN2 SSPOP PXK PRDM2 HIVEP3 NOL4L ZFHX4 MEGF9 SNAP91 VCAN NAV1 KDM2B ZFHX3 BSN SAMD14 MUC2 | 5.46e-09 | 1106 | 152 | 25 | M39071 |
| Coexpression | GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN | SFSWAP SH3BP1 NUP214 SRCAP REXO1 CIC PHF21A SCAF1 UBAP2L ZMIZ2 AGRN CNOT3 SYMPK | 9.50e-08 | 338 | 152 | 13 | M17094 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBML5 | MAP1B SPEG KIF21A KSR2 ANKS1B NFASC POU2F2 UBN2 HIVEP3 ZFHX4 NAV1 ZFHX3 BSN SAMD14 | 5.90e-07 | 465 | 152 | 14 | M39066 |
| Coexpression | GSE32255_WT_UNSTIM_VS_JMJD2D_KNOCKDOWN_4H_LPS_STIM_DC_UP | 8.88e-07 | 175 | 152 | 9 | M8908 | |
| Coexpression | HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_28DY_POSITIVE | CUX2 SFPQ OXER1 SH3RF1 C15orf39 POU2F2 PROSER1 CCDC6 RAB11FIP1 KDM6B SSPOP PXK SMTN KSR1 MIDN PPP2R5B RIPOR1 ZFHX3 ULK1 RTL8C SAP130 RAD23B | 3.36e-06 | 1250 | 152 | 22 | M41099 |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | SFPQ ARHGAP10 ZC3H13 CHD4 KDM6B BCL9 CREBBP UBAP2L PRRC2C NAV1 ZFHX3 PHLDB2 SYMPK | 3.58e-06 | 467 | 152 | 13 | M1347 |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | SFPQ ARHGAP10 ZC3H13 CHD4 KDM6B BCL9 CREBBP UBAP2L PRRC2C NAV1 ZFHX3 PHLDB2 SYMPK | 5.27e-06 | 484 | 152 | 13 | MM999 |
| Coexpression | LAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM | WIPF1 ARHGAP10 ATXN7L1 RGL3 ZC3H13 DAB1 ANKS1B CREBBP PDHX MLXIPL PRRC2C PLEKHA5 | 6.16e-06 | 417 | 152 | 12 | M39224 |
| Coexpression | NABA_ECM_AFFILIATED | 7.04e-06 | 170 | 152 | 8 | M5880 | |
| Coexpression | TABULA_MURIS_SENIS_SUBCUTANEOUS_ADIPOSE_TISSUE_EPITHELIAL_CELL_AGEING | RGL3 ZC3H13 CHD4 MUC13 KDM6B SCAF1 RBSN ZFHX4 ABI2 MAML2 SAP130 CNOT3 RAD23B | 2.85e-05 | 568 | 152 | 13 | MM3824 |
| Coexpression | WANG_CLIM2_TARGETS_UP | 2.97e-05 | 270 | 152 | 9 | M10334 | |
| Coexpression | PATIL_LIVER_CANCER | DLG5 MAP1B PODXL DTL DAB1 E2F1 RAB11FIP1 UBN2 PHF21A IGF2BP1 PIK3C3 UBAP2L PRRC2C AGRN | 3.21e-05 | 660 | 152 | 14 | M1195 |
| Coexpression | DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN | 3.53e-05 | 276 | 152 | 9 | M3063 | |
| Coexpression | NABA_ECM_AFFILIATED | 3.94e-05 | 158 | 152 | 7 | MM17063 | |
| Coexpression | GSE6269_FLU_VS_E_COLI_INF_PBMC_UP | 4.99e-05 | 164 | 152 | 7 | M5653 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN | CASC3 SH3RF1 PODXL NELFA RBL2 POGZ UBN2 MAP3K1 KSR1 RBSN ABI2 ARID2 ZFHX3 ZNF319 ZBTB3 | 7.46e-05 | 807 | 152 | 15 | M16651 |
| Coexpression | MARTENS_BOUND_BY_PML_RARA_FUSION | C15orf39 RAB11FIP1 UBN2 HIVEP3 KSR1 MLXIPL MIDN ARID2 MAML2 DCAF11 ZBTB3 | 7.53e-05 | 456 | 152 | 11 | M2094 |
| Coexpression | GSE37532_WT_VS_PPARG_KO_LN_TREG_UP | 7.80e-05 | 176 | 152 | 7 | M8952 | |
| Coexpression | CARD_MIR302A_TARGETS | 8.67e-05 | 77 | 152 | 5 | M2208 | |
| Coexpression | GRESHOCK_CANCER_COPY_NUMBER_UP | 1.18e-04 | 323 | 152 | 9 | M9150 | |
| Coexpression | GSE13485_CTRL_VS_DAY21_YF17D_VACCINE_PBMC_UP | 1.26e-04 | 190 | 152 | 7 | M3289 | |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_5_6WK_DN | 1.29e-04 | 133 | 152 | 6 | M8880 | |
| Coexpression | IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR | ABL1 POU2F2 HUWE1 MLXIPL IGF2BP1 MIDN ABI2 PRRC2C NAV1 PLEKHA5 BSN ARMH3 | 1.37e-04 | 574 | 152 | 12 | M8215 |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_5_6WK_DN | 1.52e-04 | 137 | 152 | 6 | MM990 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRN | 1.55e-04 | 335 | 152 | 9 | M39065 | |
| Coexpression | GSE17721_CTRL_VS_CPG_0.5H_BMDC_UP | 1.67e-04 | 199 | 152 | 7 | M3754 | |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_6_7WK_UP | 1.67e-04 | 199 | 152 | 7 | MM991 | |
| Coexpression | GSE3982_BASOPHIL_VS_TH1_UP | 1.67e-04 | 199 | 152 | 7 | M5564 | |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_6_7WK_UP | 1.67e-04 | 199 | 152 | 7 | M2155 | |
| Coexpression | GSE11961_MEMORY_BCELL_DAY7_VS_GERMINAL_CENTER_BCELL_DAY7_UP | 1.72e-04 | 200 | 152 | 7 | M9319 | |
| Coexpression | GSE27786_CD4_VS_CD8_TCELL_UP | 1.72e-04 | 200 | 152 | 7 | M4819 | |
| Coexpression | GSE27786_LIN_NEG_VS_CD4_TCELL_DN | 1.72e-04 | 200 | 152 | 7 | M4773 | |
| Coexpression | GSE22935_WT_VS_MYD88_KO_MACROPHAGE_12H_MBOVIS_BCG_STIM_UP | 1.72e-04 | 200 | 152 | 7 | M7764 | |
| Coexpression | IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR | ABL1 POU2F2 HUWE1 MLXIPL IGF2BP1 MIDN ABI2 PRRC2C NAV1 PLEKHA5 BSN ARMH3 | 2.06e-04 | 600 | 152 | 12 | MM1025 |
| Coexpression | JOHNSTONE_PARVB_TARGETS_3_UP | BCL9L C15orf39 PTPN23 HUWE1 MEGF9 EIF4G1 SEC16A NAV1 RIPOR1 AGRN | 2.28e-04 | 433 | 152 | 10 | M2240 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | MAP1B SPEG KIF21A NFASC CHD4 SRCAP PLEKHN1 SSC5D NOL4L PRRC2C NAV1 HELZ ZFHX3 ULK1 FLRT2 RTL8C PHLDB2 | 2.33e-04 | 1102 | 152 | 17 | M2369 |
| Coexpression | OUYANG_PROSTATE_CANCER_PROGRESSION_UP | 2.36e-04 | 21 | 152 | 3 | MM1228 | |
| Coexpression | OUYANG_PROSTATE_CANCER_PROGRESSION_UP | 2.36e-04 | 21 | 152 | 3 | M15626 | |
| Coexpression | GSE10147_IL3_AND_HIVP17_VS_IL3_AND_CPG_STIM_PDC_DN | 2.76e-04 | 153 | 152 | 6 | M350 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | MKRN4P MAP1B SPEG KIF21A NFASC CHD4 SRCAP PLEKHN1 SSC5D NOL4L PRRC2C NAV1 HELZ ZFHX3 ULK1 FLRT2 PHLDB2 | 2.93e-04 | 1124 | 152 | 17 | MM1070 |
| Coexpression | GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_TREG_CD4_TCELL_DN | 2.96e-04 | 155 | 152 | 6 | M8944 | |
| Coexpression | GSE21033_CTRL_VS_POLYIC_STIM_DC_6H_DN | 3.17e-04 | 157 | 152 | 6 | M7733 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#2_top-relative-expression-ranked_1000 | SH3RF1 SFSWAP ZC3H13 BCORL1 SRCAP CREBBP MAP3K1 SCMH1 PRRC2C EIF4G1 FLRT2 RAD23B | 9.75e-08 | 230 | 151 | 12 | gudmap_developingGonad_e16.5_ovary_1000_k2 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#2_top-relative-expression-ranked_500 | 2.45e-06 | 162 | 151 | 9 | gudmap_developingGonad_e16.5_epididymis_500_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_1000 | SFSWAP MAP1B C15orf39 NUP214 KDM6B BCL9 PHF21A IGF2BP1 NOL4L VCAN EIF4G1 PLEKHA5 AGRN | 3.92e-06 | 385 | 151 | 13 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k4 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | CUX2 SFPQ SH3RF1 SFSWAP ZC3H13 BCORL1 KDM6B SRCAP CREBBP MAP3K1 HIVEP3 SCMH1 PRRC2C EIF4G1 NAV1 ZFHX3 FLRT2 CNOT3 RAD23B | 4.29e-06 | 801 | 151 | 19 | gudmap_developingGonad_e14.5_ epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000 | SFPQ SH3RF1 SFSWAP PODXL ZC3H13 IRX3 HUWE1 KDM6B SRCAP CREBBP MAP3K1 ZFHX4 UBAP2L SCMH1 PRRC2C EIF4G1 ZFHX3 FLRT2 RAD23B | 4.53e-06 | 804 | 151 | 19 | gudmap_developingGonad_e12.5_ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_500 | SFPQ SH3RF1 SFSWAP ZC3H13 BCORL1 KDM6B SRCAP CREBBP SCMH1 PRRC2C EIF4G1 FLRT2 RAD23B | 6.96e-06 | 406 | 151 | 13 | gudmap_developingGonad_e16.5_epididymis_500 |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_500 | SFPQ SH3RF1 SFSWAP ZC3H13 IRX3 KDM6B SRCAP ZFHX4 SCMH1 EIF4G1 ZFHX3 FLRT2 RAD23B | 7.53e-06 | 409 | 151 | 13 | gudmap_developingGonad_e12.5_ovary_500 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500 | SFPQ SH3RF1 SFSWAP ZC3H13 BCORL1 KDM6B SRCAP CREBBP SCMH1 PRRC2C EIF4G1 FLRT2 RAD23B | 8.36e-06 | 413 | 151 | 13 | gudmap_developingGonad_e14.5_ epididymis_500 |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_500 | SFPQ SH3RF1 SFSWAP MAP1B ZC3H13 KDM6B IGF2BP1 ZFHX4 SCMH1 EIF4G1 ZFHX3 FLRT2 RAD23B | 9.27e-06 | 417 | 151 | 13 | gudmap_developingGonad_e11.5_ovary + mesonephros_500 |
| CoexpressionAtlas | gudmap_RNAseq_e11.5_Ureteric_stalks_2500_K0 | CUX2 SH3RF1 ARHGAP10 SPEG DTL KSR2 BCORL1 UBQLN4 CCDC6 RAB11FIP1 KDM6B SCAF1 MLXIPL IGF2BP1 MIDN SNAP91 ZMIZ2 NAV1 KDM2B ZFHX3 DCAF11 SCRIB AGRN SYMPK | 1.15e-05 | 1275 | 151 | 24 | gudmap_RNAseq_e11.5_Ureteric_stalks_2500_K0 |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#3_top-relative-expression-ranked_1000 | SFSWAP ZC3H13 BCORL1 SRCAP CREBBP MAP3K1 PRRC2C EIF4G1 FLRT2 RAD23B | 1.21e-05 | 249 | 151 | 10 | gudmap_developingGonad_P2_epididymis_1000_k3 |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_k-means-cluster#5_top-relative-expression-ranked_1000 | SFPQ SFSWAP UBQLN4 BCL9 SCAF1 IGF2BP1 UBAP2L PRRC2C EIF4G1 HELZ RTL8C CNOT3 SYMPK RAD23B | 1.33e-05 | 498 | 151 | 14 | gudmap_developingGonad_e11.5_testes_k5_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000 | SFPQ SH3RF1 SFSWAP PODXL ZC3H13 BCORL1 IRX3 LHX8 KDM6B SRCAP CREBBP MAP3K1 SNAP91 SCMH1 PRRC2C EIF4G1 FLRT2 RAD23B | 1.47e-05 | 795 | 151 | 18 | gudmap_developingGonad_e16.5_ovary_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#2_top-relative-expression-ranked_500 | MAP1B C15orf39 NUP214 KDM6B IGF2BP1 VCAN EIF4G1 PLEKHA5 AGRN | 1.93e-05 | 209 | 151 | 9 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_500_k2 |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#2_top-relative-expression-ranked_1000 | CTTNBP2 SFSWAP ZC3H13 SRCAP CREBBP SCMH1 PRRC2C EIF4G1 RAD23B | 2.00e-05 | 210 | 151 | 9 | gudmap_developingGonad_e18.5_ovary_1000_k2 |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_1000 | SFPQ CTTNBP2 SH3RF1 SFSWAP MAP1B ZC3H13 KDM6B SRCAP CREBBP IGF2BP1 ZFHX4 UBAP2L SCMH1 PRRC2C EIF4G1 ZFHX3 FLRT2 RAD23B | 2.04e-05 | 815 | 151 | 18 | gudmap_developingGonad_e11.5_ovary + mesonephros_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_200 | 2.65e-05 | 167 | 151 | 8 | gudmap_developingGonad_e14.5_ epididymis_200 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#3_top-relative-expression-ranked_1000 | SFSWAP ZC3H13 SRCAP CREBBP MAP3K1 SCMH1 PRRC2C EIF4G1 FLRT2 RAD23B | 3.02e-05 | 277 | 151 | 10 | gudmap_developingGonad_e12.5_ovary_k3_1000 |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_top-relative-expression-ranked_1000 | SFPQ SH3RF1 SFSWAP UBQLN4 KDM6B BCL9 SCAF1 IGF2BP1 ZFHX4 UBAP2L PRRC2C EIF4G1 HELZ ZFHX3 RTL8C CNOT3 SYMPK RAD23B | 3.18e-05 | 843 | 151 | 18 | gudmap_developingGonad_e11.5_testes_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#5_top-relative-expression-ranked_200 | 4.74e-05 | 91 | 151 | 6 | gudmap_developingGonad_e14.5_ epididymis_200_k5 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#2_top-relative-expression-ranked_500 | 5.43e-05 | 136 | 151 | 7 | gudmap_developingGonad_P2_epididymis_500_k2 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000 | SFPQ SH3RF1 SFSWAP ZC3H13 BCORL1 KDM6B SRCAP CREBBP SCMH1 PRRC2C EIF4G1 JAZF1 NAV1 RCOR3 FLRT2 CNOT3 RAD23B | 5.60e-05 | 799 | 151 | 17 | gudmap_developingGonad_e18.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000 | CUX2 CTTNBP2 MAP1B ATXN7L1 SPEG NUP214 HUWE1 LHX8 BCL9 NOL4L ZFHX4 VCAN PLEKHA5 FLRT2 ZNF319 SAMD14 AGRN | 6.23e-05 | 806 | 151 | 17 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_2500_k-means-cluster#2 | CUX2 RSPH4A MAP1B PRR36 RBL2 KIF21A PHF21A MLXIPL SSC5D MEGF9 SCMH1 MAMSTR JAZF1 RCOR3 SAMD14 | 7.44e-05 | 659 | 151 | 15 | Facebase_RNAseq_e10.5_Olfactory Pit_2500_K2 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000 | CUX2 SFSWAP MAP1B C15orf39 NUP214 HUWE1 KDM6B BCL9 PHF21A IGF2BP1 NOL4L ZFHX4 VCAN EIF4G1 PLEKHA5 ZFHX3 AGRN | 7.46e-05 | 818 | 151 | 17 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#5_top-relative-expression-ranked_200 | 9.25e-05 | 64 | 151 | 5 | gudmap_developingGonad_e18.5_epididymis_200_k5 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#3_top-relative-expression-ranked_1000 | SFSWAP ZC3H13 SRCAP CREBBP MAP3K1 PRRC2C EIF4G1 FLRT2 RAD23B | 1.02e-04 | 259 | 151 | 9 | gudmap_developingGonad_e12.5_epididymis_k3_1000 |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#2_top-relative-expression-ranked_1000 | CTTNBP2 SFSWAP ZC3H13 SRCAP CREBBP SCMH1 PRRC2C EIF4G1 FLRT2 RAD23B | 1.09e-04 | 323 | 151 | 10 | gudmap_developingGonad_e11.5_ovary + mesonephros_k2_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_500 | DAB1 NUP214 IRX3 LHX8 BCL9 ZFHX4 MEGF9 VCAN ZFHX3 FLRT2 AGRN | 1.13e-04 | 390 | 151 | 11 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_500 |
| CoexpressionAtlas | DevelopingKidney_e13.5_podocyte cells_emap-27773_top-relative-expression-ranked_1000 | CUX2 WIPF1 PODXL ZC3H13 DAB1 C15orf39 TNS2 IRX3 HUWE1 BCL9 PDHX ARHGEF15 PHF21A IGF2BP1 ZFHX4 RIPOR1 FLRT2 | 1.27e-04 | 855 | 151 | 17 | gudmap_developingKidney_e13.5_podocyte cells_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.28e-04 | 209 | 151 | 8 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000_k1 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#3_top-relative-expression-ranked_500 | 1.56e-04 | 161 | 151 | 7 | gudmap_developingGonad_e12.5_ovary_k3_500 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | SFPQ SH3RF1 SFSWAP ZC3H13 BCORL1 KDM6B SRCAP CREBBP MEGF9 SCMH1 PRRC2C EIF4G1 NAV1 FLRT2 CNOT3 RAD23B | 1.65e-04 | 790 | 151 | 16 | gudmap_developingGonad_e16.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#3_top-relative-expression-ranked_1000 | SFSWAP ZC3H13 BCORL1 SRCAP CREBBP PRRC2C EIF4G1 FLRT2 RAD23B | 1.88e-04 | 281 | 151 | 9 | gudmap_developingGonad_e18.5_epididymis_1000_k3 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_500 | CUX2 MAP1B C15orf39 NUP214 KDM6B IGF2BP1 ZFHX4 VCAN EIF4G1 PLEKHA5 AGRN | 1.98e-04 | 416 | 151 | 11 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_500 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | SFPQ SH3RF1 SFSWAP ZC3H13 CHD4 KDM6B SRCAP CREBBP MAP3K1 UBAP2L SCMH1 PRRC2C EIF4G1 FLRT2 CNOT3 RAD23B | 2.07e-04 | 806 | 151 | 16 | gudmap_developingGonad_e12.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.57e-04 | 243 | 151 | 8 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_100 | 3.73e-04 | 86 | 151 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_100 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#1_top-relative-expression-ranked_100 | 3.75e-04 | 48 | 151 | 4 | gudmap_developingGonad_e14.5_ epididymis_100_k1 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_top-relative-expression-ranked_1000 | CUX2 SFPQ RASGRF2 RGL3 DAB1 NUP214 HUWE1 BCL9 SRCAP SCMH1 PRRC2C ARID2 PLEKHA5 AGRN MUC20 | 4.23e-04 | 774 | 151 | 15 | gudmap_developingKidney_e15.5_cortic collect duct_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#2_top-relative-expression-ranked_500 | 4.37e-04 | 89 | 151 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_500_k2 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_500 | SFPQ SFSWAP ZC3H13 IRX3 LHX8 KDM6B SNAP91 SCMH1 EIF4G1 RAD23B | 4.63e-04 | 387 | 151 | 10 | gudmap_developingGonad_e16.5_ovary_500 |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_500 | SFPQ SFSWAP ZC3H13 BCORL1 LYVE1 PRRC2C EIF4G1 JAZF1 FLRT2 RAD23B | 5.43e-04 | 395 | 151 | 10 | gudmap_developingGonad_P2_epididymis_500 |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_1000 | SFPQ SH3RF1 SFSWAP ZC3H13 BCORL1 KDM6B SRCAP CREBBP MAP3K1 LYVE1 PRRC2C EIF4G1 JAZF1 FLRT2 RAD23B | 5.73e-04 | 797 | 151 | 15 | gudmap_developingGonad_P2_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_500 | SFPQ SH3RF1 SFSWAP ZC3H13 KDM6B PRRC2C EIF4G1 FLRT2 CNOT3 RAD23B | 6.33e-04 | 403 | 151 | 10 | gudmap_developingGonad_e12.5_epididymis_500 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_500 | SFPQ SH3RF1 SFSWAP ZC3H13 BCORL1 KDM6B PRRC2C EIF4G1 FLRT2 RAD23B | 6.46e-04 | 404 | 151 | 10 | gudmap_developingGonad_e18.5_epididymis_500 |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#3_top-relative-expression-ranked_500 | 6.48e-04 | 97 | 151 | 5 | gudmap_developingGonad_e18.5_ovary_500_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_2500_k-means-cluster#5 | CUX2 RSPH4A PRR36 RBL2 PXK PHF21A MLXIPL SSC5D MEGF9 SCMH1 MAMSTR JAZF1 RCOR3 SAMD14 | 6.57e-04 | 722 | 151 | 14 | Facebase_RNAseq_e9.5_Facial Mesenchyne_2500_K5 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_500 | 6.83e-04 | 407 | 151 | 10 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#1_top-relative-expression-ranked_1000 | 7.11e-04 | 99 | 151 | 5 | gudmap_developingGonad_e14.5_ epididymis_1000_k1 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#5_top-relative-expression-ranked_500 | 7.22e-04 | 150 | 151 | 6 | gudmap_developingGonad_e12.5_epididymis_k5_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_1000 | 7.35e-04 | 339 | 151 | 9 | gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_1000_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_1000 | CUX2 MAP1B KIF21A DAB1 HUWE1 LHX8 KDM6B CREBBP IGF2BP1 ZFHX4 SNAP91 PRRC2C VCAN PLEKHA5 AGRN | 7.47e-04 | 818 | 151 | 15 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_1000 |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#5_top-relative-expression-ranked_1000 | 7.48e-04 | 151 | 151 | 6 | gudmap_developingGonad_P2_ovary_1000_k5 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#1_top-relative-expression-ranked_500 | 7.79e-04 | 101 | 151 | 5 | gudmap_developingGonad_e14.5_ ovary_500_k1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#5_top-relative-expression-ranked_1000 | SFPQ CTTNBP2 WIPF1 HUWE1 LHX8 MIDN MEGF9 VCAN ZFHX3 SOS2 RAD23B | 8.07e-04 | 492 | 151 | 11 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000_k5 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#5 | CUX2 RSPH4A PRR36 RBL2 PXK SSC5D MEGF9 SCMH1 MAMSTR JAZF1 RCOR3 SAMD14 AGRN | 8.65e-04 | 658 | 151 | 13 | Facebase_RNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_2500_K5 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_top-relative-expression-ranked_500 | MAP1B HUWE1 KDM6B LYVE1 IGF2BP1 ZFHX4 VCAN EIF4G1 NEURL1B AGRN | 8.84e-04 | 421 | 151 | 10 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_500 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#2_top-relative-expression-ranked_200 | 9.36e-04 | 61 | 151 | 4 | gudmap_developingGonad_e12.5_epididymis_k2_200 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#2_top-relative-expression-ranked_500 | 1.01e-03 | 107 | 151 | 5 | gudmap_developingGonad_e14.5_ epididymis_500_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#4_top-relative-expression-ranked_200 | 1.01e-03 | 28 | 151 | 3 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k4_200 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.06e-03 | 63 | 151 | 4 | gudmap_developingGonad_e11.5_testes and mesonephros_k1_1000 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#5_top-relative-expression-ranked_500 | 1.10e-03 | 109 | 151 | 5 | gudmap_developingGonad_e16.5_ovary_500_k5 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Endothelial cells_emap-29977_top-relative-expression-ranked_1000 | WIPF1 MAP1B PODXL C15orf39 TNS2 NUP214 IRX3 ARHGEF15 SMTN HIVEP3 LYVE1 NOL4L RIPOR1 AGRN | 1.13e-03 | 764 | 151 | 14 | DevelopingKidney_e15.5_Endothelial cells_emap-29977_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.16e-03 | 225 | 151 | 7 | gudmap_developingGonad_e14.5_ ovary_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#2_top-relative-expression-ranked_500 | 1.19e-03 | 65 | 151 | 4 | gudmap_developingGonad_P2_ovary_500_k2 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#2_top-relative-expression-ranked_200 | 1.19e-03 | 65 | 151 | 4 | gudmap_developingGonad_e12.5_ovary_k2_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_1000 | CUX2 MAP1B DAB1 NUP214 IRX3 LHX8 BCL9 ZFHX4 MEGF9 SCMH1 VCAN ZFHX3 FLRT2 AGRN | 1.20e-03 | 769 | 151 | 14 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_2500_k-means-cluster#4 | CUX2 RSPH4A PRR36 RBL2 KIF21A DAB1 PXK MLXIPL SSC5D MEGF9 MAMSTR JAZF1 SAMD14 | 1.21e-03 | 683 | 151 | 13 | Facebase_RNAseq_e9.5_Olfactory Placode_2500_K4 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_200 | 1.22e-03 | 166 | 151 | 6 | gudmap_developingGonad_e16.5_epididymis_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_200 | 1.22e-03 | 166 | 151 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_200 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | CUX2 RSPH4A PRR36 RBL2 PXK MLXIPL SSC5D MEGF9 SCMH1 MAMSTR JAZF1 RCOR3 SAMD14 | 1.29e-03 | 688 | 151 | 13 | Facebase_RNAseq_e10.5_Mandibular Arch_2500_K5 |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#1_top-relative-expression-ranked_500 | 1.33e-03 | 67 | 151 | 4 | gudmap_developingGonad_e12.5_ovary_k1_500 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_testes_emap-29069_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.33e-03 | 67 | 151 | 4 | gudmap_developingGonad_e12.5_testes_k3_1000 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000 | SFPQ CTTNBP2 SFSWAP ZC3H13 IRX3 LHX8 KDM6B SRCAP CREBBP SCMH1 PRRC2C EIF4G1 JAZF1 RAD23B | 1.34e-03 | 778 | 151 | 14 | gudmap_developingGonad_e18.5_ovary_1000 |
| CoexpressionAtlas | DevelopingKidney_e13.5_podocyte cells_emap-27773_k-means-cluster#1_top-relative-expression-ranked_100 | 1.37e-03 | 31 | 151 | 3 | gudmap_developingKidney_e13.5_podocyte cells_100_k1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_200 | 1.38e-03 | 170 | 151 | 6 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_200 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#3_top-relative-expression-ranked_500 | 1.41e-03 | 68 | 151 | 4 | gudmap_developingGonad_e11.5_ovary + mesonephros_k3_500 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#4_top-relative-expression-ranked_500 | 1.46e-03 | 172 | 151 | 6 | gudmap_developingGonad_e11.5_ovary + mesonephros_k4_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#5_top-relative-expression-ranked_200 | 1.48e-03 | 69 | 151 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_200_k5 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.49e-03 | 375 | 151 | 9 | gudmap_developingKidney_e15.5_cortic collect duct_1000_k4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#2 | 1.51e-03 | 173 | 151 | 6 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K2 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.60e-03 | 379 | 151 | 9 | gudmap_developingKidney_e15.5_1000_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#1_top-relative-expression-ranked_100 | 1.64e-03 | 33 | 151 | 3 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_100_k1 | |
| CoexpressionAtlas | kidney single cell_e11.5_MetanephMesench_StemCellamp_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.69e-03 | 177 | 151 | 6 | gudmap_kidney single cell_e11.5_MetanephMesench_Scamp_k3_1000 | |
| CoexpressionAtlas | BM Top 100 - trachea | 1.74e-03 | 72 | 151 | 4 | BM Top 100 - trachea | |
| CoexpressionAtlas | DevelopingKidney_e13.5_podocyte cells_emap-27773_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.74e-03 | 72 | 151 | 4 | gudmap_developingKidney_e13.5_podocyte cells_1000_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#3_top-relative-expression-ranked_100 | 1.79e-03 | 34 | 151 | 3 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_100_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.80e-03 | 312 | 151 | 8 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k2 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_500 | 1.84e-03 | 387 | 151 | 9 | gudmap_developingGonad_e18.5_ovary_500 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MAP1B KIF21A CHD4 SEC31A HUWE1 MLXIPL PRRC2C SEC16A NKX6-1 PHLDB2 | 1.46e-09 | 195 | 152 | 10 | 3e519cffa6144a62b06124642a14c9ff39b76554 |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MAP1B KIF21A CHD4 SEC31A HUWE1 MLXIPL PRRC2C SEC16A NKX6-1 PHLDB2 | 1.46e-09 | 195 | 152 | 10 | 7796ea9247f4c63762f0de8490fed08b9717fa23 |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Intermediate|5w / Sample Type, Dataset, Time_group, and Cell type. | 1.86e-09 | 200 | 152 | 10 | c92e4fc0442404481fcac623d691dae6215b852d | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.17e-08 | 179 | 152 | 9 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.64e-08 | 186 | 152 | 9 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | COVID-19-Heart-Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 2.38e-07 | 184 | 152 | 8 | 21790cdfa3b4036ad413fd44b94e31563116f25f | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.81e-07 | 188 | 152 | 8 | a91443aa8fa8fa87f7501c59219daa0305bd0bbf | |
| ToppCell | 10x5'v1-week_12-13-Endothelial-stroma-tip_EC|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.17e-07 | 191 | 152 | 8 | cf1a67b7c0d5c0dc5d4d59faf9d9b1a3a1fb00e0 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.43e-07 | 193 | 152 | 8 | 08696a99309f5b088692ddac8cca35413b5e810d | |
| ToppCell | human_hepatoblastoma-Tumor_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 3.43e-07 | 193 | 152 | 8 | 503a979328c68b096680b71359a26f02fafdff35 | |
| ToppCell | Goblet_1|World / shred by cell class for nasal brushing | 3.71e-07 | 195 | 152 | 8 | d9e4889a2e7b7c97c07c15b043b77837739462e4 | |
| ToppCell | Bronchus_Control_(B.)|World / Sample group, Lineage and Cell type | 4.01e-07 | 197 | 152 | 8 | b6dff2ee108813e18657e2d8cf850e2423f8c8e9 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.50e-06 | 163 | 152 | 7 | 6bed27d2f67a430a847da5eb47878d14b4949c45 | |
| ToppCell | Endothelial-B-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 2.14e-06 | 172 | 152 | 7 | d4e98ff9c7cbc95457e1d71fa60f151a2f178dae | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.23e-06 | 173 | 152 | 7 | d56e337eae727a29cd53cfd628e1b3c0a98e1f51 | |
| ToppCell | RA-07._Pericyte|RA / Chamber and Cluster_Paper | 3.00e-06 | 181 | 152 | 7 | 8dfb42d096db6c2df9b41303a7199d134d4bff07 | |
| ToppCell | RA-07._Pericyte|World / Chamber and Cluster_Paper | 3.12e-06 | 182 | 152 | 7 | 2075efeae633550fb2eb026d0dfd741c8252482e | |
| ToppCell | LA-07._Pericyte|World / Chamber and Cluster_Paper | 3.23e-06 | 183 | 152 | 7 | e3835db4795362b0442d5893baf2a78efcc20428 | |
| ToppCell | LV-07._Pericyte|World / Chamber and Cluster_Paper | 3.23e-06 | 183 | 152 | 7 | 273db6a3b00a93ca852498471187b642b5368185 | |
| ToppCell | LA-07._Pericyte|LA / Chamber and Cluster_Paper | 3.47e-06 | 185 | 152 | 7 | ba5baa4d7f097108622674de5b7f4fd279843d24 | |
| ToppCell | LV-07._Pericyte|LV / Chamber and Cluster_Paper | 3.47e-06 | 185 | 152 | 7 | acb38eba871ec72f2a8136a33b87d33b8c85465d | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.60e-06 | 186 | 152 | 7 | bd1185592aedebccd1007dbf2dd2f549fcdf9f42 | |
| ToppCell | RV-07._Pericyte|World / Chamber and Cluster_Paper | 3.73e-06 | 187 | 152 | 7 | dc274d6bbda619a2c914d84e2b4069cfef1739d1 | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.00e-06 | 189 | 152 | 7 | 9da012fdfa9a8d488cab710a463a1d70e89f990c | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.14e-06 | 190 | 152 | 7 | 6ea9fa08bd97bedcb21d3654467e7f8dd74c8fd0 | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.28e-06 | 191 | 152 | 7 | 3307dbccadb09c62b0e1c0235ec89bb294d748c3 | |
| ToppCell | ILEUM-inflamed-(7)_Endothelial_cell-(7)_Lymphatics|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 4.43e-06 | 192 | 152 | 7 | d43caf42ec744e895137f31ef65a990e250669d2 | |
| ToppCell | Posterior_cortex-Neuronal|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 4.59e-06 | 193 | 152 | 7 | b4989e3436e84dbec3789b46057e0f7a0ebf09d4 | |
| ToppCell | Hippocampus-Neuronal|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 4.74e-06 | 194 | 152 | 7 | 8aeb347b3024354c9505f4f0fddf0b843489dc6b | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.74e-06 | 194 | 152 | 7 | 0b023de48ed8a550d169bbe954881eb04bf4f981 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.74e-06 | 194 | 152 | 7 | ebb038f94f49f5c655578d1b018676e10c6b7e3c | |
| ToppCell | (05)_Secretory|World / shred by cell type by condition | 5.07e-06 | 196 | 152 | 7 | 8032c25b51ef96aeba28cc52686a2bd45213453d | |
| ToppCell | 15-Trachea|15 / Age, Tissue, Lineage and Cell class | 5.07e-06 | 196 | 152 | 7 | fd17403422cf95c24f6be1c2d78764bb352f7f2e | |
| ToppCell | distal-Epithelial-Goblet|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.25e-06 | 197 | 152 | 7 | da1ed7303cc9cb2d205c0e5c49c52544d3540951 | |
| ToppCell | distal-3-Epithelial-Goblet|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.25e-06 | 197 | 152 | 7 | a00784ccfb1de6a96b91e2a8a2889b69f31a33da | |
| ToppCell | distal-Epithelial-Goblet-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.25e-06 | 197 | 152 | 7 | 3fbf456ae4f73da4f6254a6f0d24f0ec27d7a3cc | |
| ToppCell | proximal-3-Epithelial-Goblet|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.42e-06 | 198 | 152 | 7 | 3477202c4f702d8f75231b13d4b5216f56d981d7 | |
| ToppCell | proximal-Epithelial-Goblet|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.42e-06 | 198 | 152 | 7 | e7e1c430486a81280abc4a7e7f5bc3713dd20737 | |
| ToppCell | 10x5'v1-week_12-13-Endothelial-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.42e-06 | 198 | 152 | 7 | 122215d9288533ad03562cf777e846504863df9a | |
| ToppCell | BL-critical-LOC-Epithelial-Secretory_LYPD2|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.42e-06 | 198 | 152 | 7 | 484d16aaa601a1e11b871b0475dd01a2de1a29ce | |
| ToppCell | 10x5'v1-week_12-13-Endothelial|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.42e-06 | 198 | 152 | 7 | 307dd09e6bc820a148f3000f18dae7aedba4be0b | |
| ToppCell | proximal-Epithelial-Goblet-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.42e-06 | 198 | 152 | 7 | da7b40eb00bb5e454e1cfcd1219dc0d84712592a | |
| ToppCell | 11.5-Airway-Mesenchymal-Airway_Smooth_Muscle|Airway / Age, Tissue, Lineage and Cell class | 5.61e-06 | 199 | 152 | 7 | 1a8c77d241bd817a195e1532fd25f51358cb1ff1 | |
| ToppCell | cellseq2-Mesenchymal-Myocytic-Myocytic_2-VSMC|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.79e-06 | 200 | 152 | 7 | fc802dd73f048881d9ddafd1b79ab3ca654510e2 | |
| ToppCell | cellseq2-Mesenchymal-Myocytic-Myocytic_2|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.79e-06 | 200 | 152 | 7 | cffddb39960cd611428397c1ec4023192e8af5a7 | |
| ToppCell | cellseq2-Mesenchymal-Myocytic|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.79e-06 | 200 | 152 | 7 | e60aebd20be8012fa2febf6585ed34ebd64ec9b3 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.55e-05 | 155 | 152 | 6 | 59035d792c26d870a8b097939e97fa47859ba68c | |
| ToppCell | COVID-19-lung-Mesothelial|lung / Disease (COVID-19 only), tissue and cell type | 1.61e-05 | 156 | 152 | 6 | e1f563869b3bf997eaa2e756e31b53db1a478903 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-Basophil/Mast_cell-basophil_l26|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.45e-05 | 168 | 152 | 6 | 0e99ecd94ab8e5372e30433d7d0aa76b4d54257a | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-Basophil/Mast_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.45e-05 | 168 | 152 | 6 | 34722e14f28313f2e4644b3c1861ef12958cee9f | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-Proximal_secretory_2|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.89e-05 | 173 | 152 | 6 | d1e47c87bd4750801f3531f66a56c5dccb4ea64c | |
| ToppCell | 5'-Adult-Distal_Rectal-Epithelial-goblet-BEST2+_Goblet_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.08e-05 | 175 | 152 | 6 | 019ea30ac55748463d7917abf3d3f0e804189bfd | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.18e-05 | 176 | 152 | 6 | 90f36f10c6ed440a0ca549f23219398853f1fbc3 | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.28e-05 | 177 | 152 | 6 | 0e74980a7686c31fcf1476b8f19a3392541df240 | |
| ToppCell | 5'-Adult-Distal_Rectal-Epithelial-goblet|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.39e-05 | 178 | 152 | 6 | 9099b47e0756d6a1b7ba1c6aa7b47c5425f649e0 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.39e-05 | 178 | 152 | 6 | fcbbcc44271515de1969b4732b6441c012693d5f | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.39e-05 | 178 | 152 | 6 | 3b12db04006db6e94fc45649a4b3a63b92f21a61 | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.50e-05 | 179 | 152 | 6 | 859cd8ee414ad6207c046ada2e655e49322dd01c | |
| ToppCell | Ciliated_cells-A-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 3.61e-05 | 180 | 152 | 6 | d9be152773fe9f2160edad9246fa03c03afeafd6 | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular-Goblet|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.61e-05 | 180 | 152 | 6 | 3dc80bc636bf0e6ffc9762853132a9fe59fd1f66 | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular-Goblet-Goblet|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.61e-05 | 180 | 152 | 6 | 668a2d8e1d5a390309d5eb62c836f5903144bea9 | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.84e-05 | 182 | 152 | 6 | 573771130247e869e4e58f22d4a1cb31989635cf | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_A-Branch_A4_(IN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.84e-05 | 182 | 152 | 6 | be32b5b8153c1053cbb55f1fccfa27c3ee97c1e1 | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.84e-05 | 182 | 152 | 6 | 6cfaa2b3b3974c13b01c943f4adb70768dcc35e4 | |
| ToppCell | COVID-19-kidney-Podocyte|kidney / Disease (COVID-19 only), tissue and cell type | 3.95e-05 | 183 | 152 | 6 | fb5e2a31b560126e1c04a386c24c365901c60ad7 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.20e-05 | 185 | 152 | 6 | 51dfe6ac7df8b330343b37e3bee71e5c65267189 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Dendritic-plasmacytoid_dendritic_cell-DC_c4-LILRA4|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.20e-05 | 185 | 152 | 6 | ef3c1fd52d21d96f81fb0e5097b24be0ce16e222 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Dendritic-plasmacytoid_dendritic_cell|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.20e-05 | 185 | 152 | 6 | c357fa098b561da16c9fa82b0c3563b5cd3fa875 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_B-Branch_B3_(IPAN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.20e-05 | 185 | 152 | 6 | edb114487206e4e8df4c7878285df40f49b7fd64 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.20e-05 | 185 | 152 | 6 | a8c02cec3c414f3a0da9f2d6d28ce563b0030705 | |
| ToppCell | droplet-Bladder-nan-24m-Endothelial-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.20e-05 | 185 | 152 | 6 | 90caab8d9361a541c5d5121c97c3f1cdffeeae4a | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 4.33e-05 | 186 | 152 | 6 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| ToppCell | droplet-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.33e-05 | 186 | 152 | 6 | 9c7924875f70420720149287c500b4dfa8d24673 | |
| ToppCell | Nasal_Brush-Immune-Neutrophils|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X | 4.33e-05 | 186 | 152 | 6 | f5aa91dbef29f7efa2b9a728c6539d7541340cd4 | |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 4.33e-05 | 186 | 152 | 6 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 4.33e-05 | 186 | 152 | 6 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | RV-07._Pericyte|RV / Chamber and Cluster_Paper | 4.33e-05 | 186 | 152 | 6 | c533b264fbe12bc35467486fc7fbde24ba968fe1 | |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | 4.46e-05 | 187 | 152 | 6 | 464a0c3b92b778911b5f9cd73642e09e3472063a | |
| ToppCell | droplet-Lung-18m-Endothelial-arterial_endothelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.46e-05 | 187 | 152 | 6 | 12129e02638c20d9b7c1c6e512d48bfd966e1029 | |
| ToppCell | 15-Trachea-Epithelial-Secretory_progenitor|Trachea / Age, Tissue, Lineage and Cell class | 4.46e-05 | 187 | 152 | 6 | be9fce9e74b2f170a2067f1b31d802912a578329 | |
| ToppCell | droplet-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.46e-05 | 187 | 152 | 6 | 83930ef55191eff9006113feaeabb3c2fa21fd05 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T2|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 4.46e-05 | 187 | 152 | 6 | f3e37c18ac6471c7992609bbddfa4975571c815c | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.46e-05 | 187 | 152 | 6 | 24c2a3962da364e46e98abeab5f8234376fa26bb | |
| ToppCell | Pericytes-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 4.60e-05 | 188 | 152 | 6 | 14c1c88a944c66f2eaac1ce7526815dcce1f5147 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.60e-05 | 188 | 152 | 6 | aeecbc057dc823f8fcea8a98f18d213bacc7f4db | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.73e-05 | 189 | 152 | 6 | 965e0e388251e7318f8b463816dc96ccb4658677 | |
| ToppCell | human_hepatoblastoma-Endothelial_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 4.87e-05 | 190 | 152 | 6 | 8d6ef93d69e96cd6921816d152bea3b0710cf147 | |
| ToppCell | droplet-Thymus-nan-18m-Lymphocytic-Double_negative_Thymocyte,_DN4_(Cd8-,_Cd4-),_some_undergoing_VDJ_recombination_|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.87e-05 | 190 | 152 | 6 | 8f5e71a0861ee4e8f3ce45e8a7f18fb9d6036a3c | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.87e-05 | 190 | 152 | 6 | 2fdc024d3d673a0134b74b4c5a63afe924995730 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.02e-05 | 191 | 152 | 6 | f663131a4810584c5854bd64ee7991a237b7707f | |
| ToppCell | Healthy_Control-Epithelial-Epithelial-|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 5.02e-05 | 191 | 152 | 6 | 28caedb2e448e0c7f494100d714fa7cdcf150691 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.02e-05 | 191 | 152 | 6 | cd709bbcd320373468ea7f058ee5fda8a067b5d0 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.02e-05 | 191 | 152 | 6 | 14851529025cfc2b665f71ebad04150ec543da7a | |
| ToppCell | Healthy_Control-Epithelial-Epithelial|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 5.02e-05 | 191 | 152 | 6 | 15b9386b26caaa7d15f704c4a18881e1ce918a21 | |
| ToppCell | Healthy_Control-Epithelial|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 5.02e-05 | 191 | 152 | 6 | fdcdadbfc9ccae175abe4de8c7428ac4f6a67fde | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.02e-05 | 191 | 152 | 6 | 529068029fb461df766135576dd0d8b5980f9bc0 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.02e-05 | 191 | 152 | 6 | e14b22e882ac92acf8c8b6ee997ef8e799c7a8d5 | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-Early_airway_SMC_1|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 5.17e-05 | 192 | 152 | 6 | 7ae3e1ca8bfc078c0e12a1595ecb0e343dab5d2f | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Degenerative_Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.17e-05 | 192 | 152 | 6 | ef0aba777072429a6ab7dcfcc305673975946580 | |
| ToppCell | droplet-Pancreas-Endocrine|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.17e-05 | 192 | 152 | 6 | 0dfd1e9896c34aee0f842f8de5d0e3af62a15f68 | |
| Drug | Serotonin hydrochloride [153-98-0]; Up 200; 18.8uM; PC3; HT_HG-U133A | RAD52 MAP1B TBC1D2B KDM6B MAP3K1 PRDM2 PYHIN1 LYVE1 MEGF9 SUGP1 SYMPK | 8.75e-08 | 196 | 152 | 11 | 4673_UP |
| Drug | 17-AAG; Down 200; 1uM; PC3; HT_HG-U133A | C15orf39 E2F1 CC2D1A POGZ PPFIA3 KDM6B SMTN ZMIZ2 SUGP1 RIPOR1 | 5.92e-07 | 189 | 152 | 10 | 1206_DN |
| Drug | Metrizamide [31112-62-6]; Up 200; 5uM; MCF7; HT_HG-U133A | WIPF1 SPEG PLA2G3 NUP214 PRDM2 PYHIN1 PPP2R5B MEGF9 SUGP1 RAD23B | 8.65e-07 | 197 | 152 | 10 | 3255_UP |
| Drug | Nifurtimox [23256-30-6]; Up 200; 14uM; PC3; HT_HG-U133A | 9.49e-07 | 199 | 152 | 10 | 6608_UP | |
| Drug | Mevalonic-D, L acid lactone [674-26-0]; Down 200; 30.8uM; MCF7; HT_HG-U133A | 6.74e-06 | 195 | 152 | 9 | 3459_DN | |
| Drug | Lasalocid sodium salt [25999-20-6]; Up 200; 6.6uM; MCF7; HT_HG-U133A | 7.02e-06 | 196 | 152 | 9 | 3360_UP | |
| Drug | Fenoprofen calcium salt dihydrate [53746-45-5]; Down 200; 7.2uM; HL60; HT_HG-U133A | BCORL1 TBC1D2B CC2D1A RAB11FIP1 KDM6B MEGF9 ABI2 SUGP1 FLRT2 | 7.02e-06 | 196 | 152 | 9 | 2553_DN |
| Drug | Clindamycin hydrochloride [21462-39-5]; Down 200; 8.6uM; PC3; HT_HG-U133A | 7.32e-06 | 197 | 152 | 9 | 5815_DN | |
| Drug | Hydroxytacrine maleate (R,S) [118909-22-1]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 7.62e-06 | 198 | 152 | 9 | 3292_DN | |
| Drug | Methazolamide [554-57-4]; Down 200; 17uM; MCF7; HT_HG-U133A | 7.94e-06 | 199 | 152 | 9 | 6268_DN | |
| Drug | Sparteine (-) [90-39-1]; Down 200; 17uM; HL60; HT_HG-U133A | 8.27e-06 | 200 | 152 | 9 | 2134_DN | |
| Drug | alpha-ketoisovalerate | 2.95e-05 | 89 | 152 | 6 | CID000000049 | |
| Drug | Muramic acid, N-acetyl [10597-89-4]; Up 200; 13.6uM; MCF7; HT_HG-U133A | 4.77e-05 | 193 | 152 | 8 | 3262_UP | |
| Drug | Glycocholic acid [475-31-0]; Down 200; 8.6uM; PC3; HT_HG-U133A | 4.77e-05 | 193 | 152 | 8 | 6716_DN | |
| Drug | Ricinine [524-40-3]; Down 200; 24.4uM; HL60; HT_HG-U133A | 4.77e-05 | 193 | 152 | 8 | 2505_DN | |
| Drug | Ethacrynic acid [58-54-8]; Down 200; 13.2uM; MCF7; HT_HG-U133A | 4.77e-05 | 193 | 152 | 8 | 3181_DN | |
| Drug | Fluvastatin sodium salt [93957-55-2]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 4.77e-05 | 193 | 152 | 8 | 3370_UP | |
| Drug | Proglumide [6620-60-6]; Down 200; 12uM; MCF7; HT_HG-U133A | 4.95e-05 | 194 | 152 | 8 | 3861_DN | |
| Drug | Sulfaquinoxaline sodium salt [967-80-6]; Down 200; 12.4uM; MCF7; HT_HG-U133A | 4.95e-05 | 194 | 152 | 8 | 6090_DN | |
| Drug | Oxprenolol hydrochloride [6452-73-9]; Down 200; 13.2uM; MCF7; HT_HG-U133A | 5.13e-05 | 195 | 152 | 8 | 7225_DN | |
| Drug | Trimethobenzamide hydrochloride [554-92-7]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 5.13e-05 | 195 | 152 | 8 | 4180_DN | |
| Drug | Flunixin meglumine [42461-84-7]; Down 200; 8.2uM; HL60; HT_HG-U133A | 5.13e-05 | 195 | 152 | 8 | 2552_DN | |
| Drug | Cyclopenthiazide [742-20-1]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 5.13e-05 | 195 | 152 | 8 | 4813_UP | |
| Drug | Pronethalol hydrochloride [51-02-5]; Down 200; 15uM; PC3; HT_HG-U133A | 5.13e-05 | 195 | 152 | 8 | 3984_DN | |
| Drug | Cefepime hydrochloride [123171-59-5]; Down 200; 7.4uM; HL60; HT_HG-U133A | 5.13e-05 | 195 | 152 | 8 | 6159_DN | |
| Drug | Sulfadiazine [68-35-9]; Up 200; 16uM; HL60; HT_HG-U133A | 5.32e-05 | 196 | 152 | 8 | 1852_UP | |
| Drug | Pirenzepine dihydrochloride [29868-97-1]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 5.32e-05 | 196 | 152 | 8 | 7226_DN | |
| Drug | sulfasalazine; Down 200; 100uM; MCF7; HG-U133A | 5.32e-05 | 196 | 152 | 8 | 204_DN | |
| Drug | ikarugamycin; Up 200; 2uM; MCF7; HT_HG-U133A_EA | 5.32e-05 | 196 | 152 | 8 | 918_UP | |
| Drug | Dipivefrin hydrochloride [64019-93-8]; Down 200; 10.4uM; PC3; HT_HG-U133A | 5.32e-05 | 196 | 152 | 8 | 7124_DN | |
| Drug | Mifepristone [84371-65-3]; Down 200; 9.4uM; PC3; HT_HG-U133A | 5.32e-05 | 196 | 152 | 8 | 5827_DN | |
| Drug | Ketoprofen [22071-15-4]; Up 200; 15.8uM; PC3; HT_HG-U133A | 5.32e-05 | 196 | 152 | 8 | 3729_UP | |
| Drug | Merbromin [129-16-8]; Down 200; 5uM; MCF7; HT_HG-U133A | 5.52e-05 | 197 | 152 | 8 | 3439_DN | |
| Drug | N6-methyladenosine [1867-73-8]; Down 200; 14.2uM; MCF7; HT_HG-U133A | 5.52e-05 | 197 | 152 | 8 | 5332_DN | |
| Drug | Isoniazid [54-85-3]; Down 200; 29.2uM; MCF7; HT_HG-U133A | 5.52e-05 | 197 | 152 | 8 | 7197_DN | |
| Drug | Bethanechol chloride [590-63-6]; Down 200; 20.4uM; HL60; HT_HG-U133A | 5.52e-05 | 197 | 152 | 8 | 2975_DN | |
| Drug | Pseudopelletierine hydrochloride [6164-62-1]; Up 200; 21uM; MCF7; HT_HG-U133A | 5.52e-05 | 197 | 152 | 8 | 2766_UP | |
| Drug | Practolol [6673-35-4]; Up 200; 15uM; PC3; HT_HG-U133A | 5.72e-05 | 198 | 152 | 8 | 4603_UP | |
| Drug | Chlorhexidine [55-56-1]; Down 200; 8uM; PC3; HT_HG-U133A | 5.72e-05 | 198 | 152 | 8 | 6302_DN | |
| Drug | Nifenazone [2139-47-1]; Down 200; 13uM; MCF7; HT_HG-U133A | 5.72e-05 | 198 | 152 | 8 | 6016_DN | |
| Drug | Enoxacin [74011-58-8]; Up 200; 12.4uM; PC3; HT_HG-U133A | 5.72e-05 | 198 | 152 | 8 | 4655_UP | |
| Drug | copper(II) sulfate pentahydrate; Down 200; 100uM; PC3; HG-U133A | 5.72e-05 | 198 | 152 | 8 | 459_DN | |
| Drug | Tinidazole [19387-91-8]; Down 200; 16.2uM; MCF7; HT_HG-U133A | 5.72e-05 | 198 | 152 | 8 | 4370_DN | |
| Drug | Hydroquinine hydrobromide hydrate [304695-81-6]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 5.72e-05 | 198 | 152 | 8 | 2767_DN | |
| Drug | THIP Hydrochloride; Down 200; 22.6uM; PC3; HT_HG-U133A | 5.72e-05 | 198 | 152 | 8 | 7266_DN | |
| Drug | Iocetamic acid [16034-77-8]; Up 200; 6.6uM; MCF7; HT_HG-U133A | 5.72e-05 | 198 | 152 | 8 | 4425_UP | |
| Drug | Heptaminol hydrochloride [543-15-7]; Down 200; 22uM; PC3; HT_HG-U133A | 5.72e-05 | 198 | 152 | 8 | 1825_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A | 5.92e-05 | 199 | 152 | 8 | 4348_UP | |
| Drug | Hydroquinine hydrobromide hydrate [304695-81-6]; Down 200; 9.4uM; PC3; HT_HG-U133A | 5.92e-05 | 199 | 152 | 8 | 5789_DN | |
| Drug | Ornidazole [16773-42-5]; Down 200; 18.2uM; PC3; HT_HG-U133A | 5.92e-05 | 199 | 152 | 8 | 2109_DN | |
| Drug | clozapine; Down 200; 10uM; PC3; HT_HG-U133A | 5.92e-05 | 199 | 152 | 8 | 1229_DN | |
| Drug | Resveratrol [501-36-0]; Up 200; 17.6uM; MCF7; HT_HG-U133A | 5.92e-05 | 199 | 152 | 8 | 5509_UP | |
| Drug | Bacampicillin hydrochloride [37661-08-8]; Up 200; 8uM; MCF7; HT_HG-U133A | 5.92e-05 | 199 | 152 | 8 | 3273_UP | |
| Drug | 2-propylpentanoic acid; Up 200; 50uM; MCF7; HT_HG-U133A | 5.92e-05 | 199 | 152 | 8 | 5219_UP | |
| Drug | tetraethylenepentamine pentahydrochloride; Up 200; 10uM; MCF7; HG-U133A | 5.92e-05 | 199 | 152 | 8 | 405_UP | |
| Drug | Mafenide hydrochloride [138-37-4]; Down 200; 18uM; MCF7; HT_HG-U133A | 5.92e-05 | 199 | 152 | 8 | 2287_DN | |
| Drug | Iohexol [66108-95-0]; Up 200; 4.8uM; MCF7; HT_HG-U133A | 6.14e-05 | 200 | 152 | 8 | 3322_UP | |
| Drug | Meclozine dihydrochloride [1104-22-9]; Up 200; 8.6uM; PC3; HT_HG-U133A | 6.14e-05 | 200 | 152 | 8 | 4646_UP | |
| Drug | flufenamic acid; Down 200; 10uM; MCF7; HG-U133A | 6.14e-05 | 200 | 152 | 8 | 316_DN | |
| Drug | (R)-(+)-Atenolol [56715-13-0]; Down 200; 15uM; MCF7; HT_HG-U133A | 6.14e-05 | 200 | 152 | 8 | 4841_DN | |
| Drug | 6,7-dimethoxy-2-(pyrrolidin-1-yl)-N-(5-(pyrrolidin-1-yl)pentyl)quinazolin-4-amine | 7.10e-05 | 104 | 152 | 6 | ctd:C000595015 | |
| Drug | Thomsen-Friedenreich antigen | 7.43e-05 | 65 | 152 | 5 | CID000065121 | |
| Drug | cellobiitol | 1.06e-04 | 37 | 152 | 4 | CID000003871 | |
| Drug | pyrvinium pamoate; Up 200; 1.25uM; MCF7; HT_HG-U133A_EA | 1.49e-04 | 170 | 152 | 7 | 978_UP | |
| Drug | guanidine hydrochloride | 2.32e-04 | 129 | 152 | 6 | CID000005742 | |
| Drug | Hexetidine [141-94-6]; Up 200; 11.8uM; HL60; HT_HG-U133A | 2.51e-04 | 185 | 152 | 7 | 2457_UP | |
| Drug | Pyrvinium pamoate [3546-41-6]; Down 200; 3.4uM; MCF7; HT_HG-U133A | 2.59e-04 | 186 | 152 | 7 | 3518_DN | |
| Drug | 17-AAG; Down 200; 1uM; PC3; HT_HG-U133A | 2.76e-04 | 188 | 152 | 7 | 5958_DN | |
| Drug | Mometasone furoate [83919-23-7]; Down 200; 7.6uM; PC3; HT_HG-U133A | 2.76e-04 | 188 | 152 | 7 | 5116_DN | |
| Drug | Eburnamonine (-) [4880-88-0]; Down 200; 13.6uM; PC3; HT_HG-U133A | 2.95e-04 | 190 | 152 | 7 | 7154_DN | |
| Drug | trofosfamide | 2.96e-04 | 48 | 152 | 4 | CID000065702 | |
| Drug | Norcyclobenzaprine [303-50-4]; Up 200; 15.4uM; PC3; HT_HG-U133A | 3.04e-04 | 191 | 152 | 7 | 4190_UP | |
| Drug | rottlerin; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 3.04e-04 | 191 | 152 | 7 | 941_DN | |
| Drug | Rapamycin; Up 200; 0.1uM; PC3; HT_HG-U133A | 3.14e-04 | 192 | 152 | 7 | 1221_UP | |
| Drug | CP-320650-01 [172079-28-6]; Down 200; 1uM; MCF7; HT_HG-U133A | 3.24e-04 | 193 | 152 | 7 | 3908_DN | |
| Drug | geldanamycin; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 3.24e-04 | 193 | 152 | 7 | 864_DN | |
| Drug | Metoclopramide monohydrochloride [7232-21-5]; Down 200; 11.8uM; PC3; HT_HG-U133A | 3.24e-04 | 193 | 152 | 7 | 4285_DN | |
| Drug | geldanamycin; Down 200; 1uM; PC3; HT_HG-U133A | 3.24e-04 | 193 | 152 | 7 | 1228_DN | |
| Drug | Etofylline [519-37-9]; Up 200; 17.8uM; PC3; HT_HG-U133A | 3.24e-04 | 193 | 152 | 7 | 2093_UP | |
| Drug | 5211181; Up 200; 12uM; MCF7; HT_HG-U133A_EA | 3.24e-04 | 193 | 152 | 7 | 950_UP | |
| Drug | Isoquinoline, 6,7-dimethoxy-1-methyl-1,2,3,4-tetrahydro, hydrochloride; Down 200; 16.4uM; MCF7; HT_HG-U133A | 3.34e-04 | 194 | 152 | 7 | 2824_DN | |
| Drug | Pridinol methanesulfonate salt [6856-31-1]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 3.34e-04 | 194 | 152 | 7 | 7214_DN | |
| Drug | Nifedipine [21829-25-4]; Up 200; 11.6uM; PC3; HT_HG-U133A | 3.34e-04 | 194 | 152 | 7 | 1814_UP | |
| Drug | chlorpromazine hydrochloride; Down 200; 1uM; MCF7; HT_HG-U133A | 3.34e-04 | 194 | 152 | 7 | 1642_DN | |
| Drug | Urapidil hydrochloride [64887-14-5]; Up 200; 9.4uM; PC3; HT_HG-U133A | 3.34e-04 | 194 | 152 | 7 | 6696_UP | |
| Drug | Prilocaine hydrochloride [1786-81-8]; Down 200; 15.6uM; PC3; HT_HG-U133A | 3.34e-04 | 194 | 152 | 7 | 4284_DN | |
| Drug | GSK-3 Inhibitor IX; Up 200; 0.5uM; MCF7; HT_HG-U133A | 3.34e-04 | 194 | 152 | 7 | 7044_UP | |
| Drug | Retrorsine [480-54-6]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 3.34e-04 | 194 | 152 | 7 | 2784_DN | |
| Drug | Pizotifen malate [5189-11-7]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 3.34e-04 | 194 | 152 | 7 | 5491_DN | |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A | 3.34e-04 | 194 | 152 | 7 | 5914_DN | |
| Drug | PNU-0230031 [267429-39-0]; Down 200; 1uM; PC3; HT_HG-U133A | 3.34e-04 | 194 | 152 | 7 | 4291_DN | |
| Drug | radicicol; Down 200; 0.1uM; PC3; HT_HG-U133A | 3.34e-04 | 194 | 152 | 7 | 5952_DN | |
| Drug | Ipratropium bromide [22254-24-6]; Down 200; 9.8uM; MCF7; HT_HG-U133A | 3.45e-04 | 195 | 152 | 7 | 2762_DN | |
| Drug | Ofloxacin [82419-36-1]; Down 200; 11uM; HL60; HT_HG-U133A | 3.45e-04 | 195 | 152 | 7 | 2340_DN | |
| Drug | Flecainide acetate [54143-56-5]; Up 200; 8.4uM; MCF7; HT_HG-U133A | 3.45e-04 | 195 | 152 | 7 | 3843_UP | |
| Drug | Risperidone [106266-06-2]; Down 200; 9.8uM; MCF7; HT_HG-U133A | 3.45e-04 | 195 | 152 | 7 | 3508_DN | |
| Drug | (R)-Propranolol hydrochloride [13071-11-9]; Down 200; 13.6uM; PC3; HT_HG-U133A | 3.45e-04 | 195 | 152 | 7 | 5814_DN | |
| Drug | Nifenazone [2139-47-1]; Down 200; 13uM; PC3; HT_HG-U133A | 3.45e-04 | 195 | 152 | 7 | 2122_DN | |
| Drug | Hecogenin [467-55-0]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 3.45e-04 | 195 | 152 | 7 | 3457_DN | |
| Drug | Pivmecillinam hydrochloride [32887-03-9]; Down 200; 8.4uM; HL60; HT_HG-U133A | 3.45e-04 | 195 | 152 | 7 | 2973_DN | |
| Disease | mucinous adenocarcinoma (is_marker_for) | 3.20e-09 | 5 | 150 | 4 | DOID:3030 (is_marker_for) | |
| Disease | testosterone measurement | CASC3 CUX2 NYAP2 SPEM3 ARHGAP10 BCORL1 UBQLN4 ANKS1B R3HDM2 KDM6B SRCAP REXO1 ARHGEF15 MLXIPL ZFHX4 CGB2 JAZF1 ZFHX3 MED12 SOS2 | 7.69e-06 | 1275 | 150 | 20 | EFO_0004908 |
| Disease | Adenoid Cystic Carcinoma | 1.26e-05 | 100 | 150 | 6 | C0010606 | |
| Disease | Paroxysmal atrial fibrillation | 1.58e-05 | 156 | 150 | 7 | C0235480 | |
| Disease | familial atrial fibrillation | 1.58e-05 | 156 | 150 | 7 | C3468561 | |
| Disease | Persistent atrial fibrillation | 1.58e-05 | 156 | 150 | 7 | C2585653 | |
| Disease | Atrial Fibrillation | 1.86e-05 | 160 | 150 | 7 | C0004238 | |
| Disease | cholangiocarcinoma (is_marker_for) | 1.90e-05 | 64 | 150 | 5 | DOID:4947 (is_marker_for) | |
| Disease | cystitis (is_marker_for) | 2.57e-05 | 2 | 150 | 2 | DOID:1679 (is_marker_for) | |
| Disease | pulse pressure measurement | CUX2 NYAP2 WIPF1 MAP1B PODXL RGL3 POGZ CCDC6 KDM6B SRCAP SSPOP HIVEP3 ZFHX4 ABI2 NAV1 ZFHX3 DLEC1 NEURL1B ARMH3 SOS2 | 2.72e-05 | 1392 | 150 | 20 | EFO_0005763 |
| Disease | glycoprotein measurement | 3.38e-05 | 119 | 150 | 6 | EFO_0004555 | |
| Disease | FEV/FEC ratio | CTTNBP2 SPEG KSR2 ANKS1B R3HDM2 PDHX MAP3K1 SMTN HIVEP3 NOL4L NAV1 RIPOR1 ZFHX3 DLEC1 MAML2 ZNF319 PHLDB2 RAD23B | 5.49e-05 | 1228 | 150 | 18 | EFO_0004713 |
| Disease | Agents acting on the renin-angiotensin system use measurement | 5.75e-05 | 335 | 150 | 9 | EFO_0009931 | |
| Disease | alcohol consumption measurement | DLG5 CUX2 NYAP2 CTTNBP2 RASGRF2 ANKS1B POU2F2 MLXIPL IGF2BP1 MEGF9 SNAP91 ABI2 ARID2 EIF4G1 MAMSTR RCOR3 ZFHX3 AGRN | 6.34e-05 | 1242 | 150 | 18 | EFO_0007878 |
| Disease | sputum mucin-5B amount | 7.68e-05 | 3 | 150 | 2 | OBA_2050332 | |
| Disease | keratoconjunctivitis (is_marker_for) | 7.68e-05 | 3 | 150 | 2 | DOID:9368 (is_marker_for) | |
| Disease | Prostatic Neoplasms | PODXL CREBBP MAP3K1 PYHIN1 TIRAP ARID2 JAZF1 ZFHX3 MUC4 MED12 CNOT3 RAD23B | 7.77e-05 | 616 | 150 | 12 | C0033578 |
| Disease | Malignant neoplasm of prostate | PODXL CREBBP MAP3K1 PYHIN1 TIRAP ARID2 JAZF1 ZFHX3 MUC4 MED12 CNOT3 RAD23B | 7.77e-05 | 616 | 150 | 12 | C0376358 |
| Disease | atrial fibrillation | 1.25e-04 | 371 | 150 | 9 | EFO_0000275 | |
| Disease | free androgen index | 1.33e-04 | 374 | 150 | 9 | EFO_0007005 | |
| Disease | concentration of chylomicrons and extremely large VLDL particles measurement | 2.35e-04 | 59 | 150 | 4 | EFO_0022260 | |
| Disease | mucositis (biomarker_via_orthology) | 2.54e-04 | 5 | 150 | 2 | DOID:0080178 (biomarker_via_orthology) | |
| Disease | pancreatic ductal carcinoma (is_marker_for) | 2.67e-04 | 61 | 150 | 4 | DOID:3587 (is_marker_for) | |
| Disease | total lipids in chylomicrons and extremely large VLDL measurement | 2.85e-04 | 62 | 150 | 4 | EFO_0022306 | |
| Disease | non-high density lipoprotein cholesterol measurement | NYAP2 DAB1 POU2F2 R3HDM2 PXK ARHGEF15 MLXIPL SUGP1 MAMSTR JAZF1 HELZ MUC7 | 3.00e-04 | 713 | 150 | 12 | EFO_0005689 |
| Disease | phospholipids in chylomicrons and extremely large VLDL measurement | 3.03e-04 | 63 | 150 | 4 | EFO_0022292 | |
| Disease | triglycerides in very small VLDL measurement | 4.06e-04 | 68 | 150 | 4 | EFO_0022144 | |
| Disease | cardiac arrhythmia | 4.73e-04 | 30 | 150 | 3 | EFO_0004269 | |
| Disease | biliary tract benign neoplasm (is_marker_for) | 5.30e-04 | 7 | 150 | 2 | DOID:0050625 (is_marker_for) | |
| Disease | cortical thickness | NYAP2 CTTNBP2 DAB1 PXK MAP3K1 IGF2BP1 NOL4L MEGF9 SNAP91 GLI4 VCAN NAV1 DLEC1 SOS2 RAD23B | 5.71e-04 | 1113 | 150 | 15 | EFO_0004840 |
| Disease | neuroticism measurement, cognitive function measurement | CTTNBP2 RBL2 ANKS1B R3HDM2 LHX8 SCAF1 IGF2BP1 ZMIZ2 NAV1 ZFHX3 | 6.63e-04 | 566 | 150 | 10 | EFO_0007660, EFO_0008354 |
| Disease | common bile duct neoplasm (is_marker_for) | 7.04e-04 | 8 | 150 | 2 | DOID:4608 (is_marker_for) | |
| Disease | glucose measurement | 7.56e-04 | 380 | 150 | 8 | EFO_0004468 | |
| Disease | bringing up phlegm, sputum or mucus on most days, self-reported | 9.03e-04 | 9 | 150 | 2 | EFO_0009824 | |
| Disease | rectum cancer (is_implicated_in) | 9.03e-04 | 9 | 150 | 2 | DOID:1993 (is_implicated_in) | |
| Disease | acute myeloid leukemia (is_implicated_in) | 9.03e-04 | 84 | 150 | 4 | DOID:9119 (is_implicated_in) | |
| Disease | peak expiratory flow | 1.05e-03 | 498 | 150 | 9 | EFO_0009718 | |
| Disease | dry eye syndrome (is_marker_for) | 1.12e-03 | 10 | 150 | 2 | DOID:10140 (is_marker_for) | |
| Disease | otitis media (is_marker_for) | 1.12e-03 | 10 | 150 | 2 | DOID:10754 (is_marker_for) | |
| Disease | allergic conjunctivitis (is_marker_for) | 1.12e-03 | 10 | 150 | 2 | DOID:11204 (is_marker_for) | |
| Disease | stromal cell-derived factor 1 alpha measurement | 1.37e-03 | 43 | 150 | 3 | EFO_0008293 | |
| Disease | pulmonary fibrosis | 1.37e-03 | 11 | 150 | 2 | EFO_0009448 | |
| Disease | smoking cessation | 1.42e-03 | 325 | 150 | 7 | EFO_0004319 | |
| Disease | obsolete_red blood cell distribution width | NYAP2 ABL1 CIART MAPK1IP1L C19orf47 R3HDM2 CHD4 REXO1 MAP3K1 KSR1 MLXIPL NOL4L PRRC2C KDM2B NEURL1B MUC4 | 1.42e-03 | 1347 | 150 | 16 | EFO_0005192 |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, lipid measurement | 1.43e-03 | 95 | 150 | 4 | EFO_0004529, EFO_0008317, EFO_0008596 | |
| Disease | triglyceride measurement, alcohol drinking | 1.66e-03 | 99 | 150 | 4 | EFO_0004329, EFO_0004530 | |
| Disease | pneumonia | 1.77e-03 | 47 | 150 | 3 | EFO_0003106 | |
| Disease | triglyceride measurement, alcohol consumption measurement | 1.79e-03 | 101 | 150 | 4 | EFO_0004530, EFO_0007878 | |
| Disease | Vitiligo, response to rhododendrol | 1.93e-03 | 13 | 150 | 2 | EFO_0004208, EFO_0010824 | |
| Disease | body weight | RAD52 CUX2 SH3RF1 DTL KSR2 ANKS1B HUWE1 PPFIA3 PHF21A NOL4L SCMH1 ZMIZ2 JAZF1 ZFHX3 SCRIB | 1.97e-03 | 1261 | 150 | 15 | EFO_0004338 |
| Disease | hematocrit | NYAP2 ARHGAP10 BCORL1 UBQLN4 R3HDM2 PXK ARHGEF15 MIDN ARID2 ZMIZ2 MAMSTR MAML2 BSN | 2.02e-03 | 1011 | 150 | 13 | EFO_0004348 |
| Disease | Intellectual Disability | 2.11e-03 | 447 | 150 | 8 | C3714756 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement | 2.13e-03 | 106 | 150 | 4 | EFO_0008317, EFO_0008596 | |
| Disease | cognitive function measurement, self reported educational attainment | 2.33e-03 | 355 | 150 | 7 | EFO_0004784, EFO_0008354 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, phospholipid measurement | 2.36e-03 | 109 | 150 | 4 | EFO_0004639, EFO_0008317, EFO_0008596 | |
| Disease | cardiovascular disease | 2.42e-03 | 457 | 150 | 8 | EFO_0000319 | |
| Disease | cholesteryl ester measurement, chylomicron measurement, very low density lipoprotein cholesterol measurement | 2.44e-03 | 110 | 150 | 4 | EFO_0008317, EFO_0008596, EFO_0010351 | |
| Disease | free cholesterol measurement, chylomicron measurement, very low density lipoprotein cholesterol measurement | 2.44e-03 | 110 | 150 | 4 | EFO_0008317, EFO_0008591, EFO_0008596 | |
| Disease | chylomicron measurement, total cholesterol measurement, very low density lipoprotein cholesterol measurement | 2.44e-03 | 110 | 150 | 4 | EFO_0004574, EFO_0008317, EFO_0008596 | |
| Disease | HbA1c measurement | 2.45e-03 | 675 | 150 | 10 | EFO_0004541 | |
| Disease | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 2.50e-03 | 53 | 150 | 3 | C1961099 | |
| Disease | triglyceride measurement, intermediate density lipoprotein measurement | 2.52e-03 | 111 | 150 | 4 | EFO_0004530, EFO_0008595 | |
| Disease | low density lipoprotein triglyceride measurement | 2.58e-03 | 15 | 150 | 2 | EFO_0009946 | |
| Disease | linoleic acid measurement | 2.67e-03 | 186 | 150 | 5 | EFO_0006807 | |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | NYAP2 CTTNBP2 RASGRF2 DAB1 NFASC LHX8 PHF21A UBAP2L HELZ PLEKHA5 ZFHX3 | 2.71e-03 | 801 | 150 | 11 | EFO_0003888, EFO_0007052, MONDO_0002491 |
| Disease | triglycerides in LDL measurement | 2.93e-03 | 56 | 150 | 3 | EFO_0022320 | |
| Disease | triglycerides in very large VLDL measurement | 2.93e-03 | 56 | 150 | 3 | EFO_0022325 | |
| Disease | triglycerides to total lipids in medium HDL percentage | 2.93e-03 | 56 | 150 | 3 | EFO_0022333 | |
| Disease | triglycerides in chylomicrons and extremely large VLDL measurement | 2.93e-03 | 56 | 150 | 3 | EFO_0022316 | |
| Disease | cholesteryl esters to total lipids in medium HDL percentage | 2.93e-03 | 56 | 150 | 3 | EFO_0022251 | |
| Disease | intracerebral hemorrhage | 2.94e-03 | 16 | 150 | 2 | EFO_0005669 | |
| Disease | galectin-3 measurement | 2.94e-03 | 16 | 150 | 2 | EFO_0008137 | |
| Disease | preeclampsia, hypertension, pregnancy-induced | 2.94e-03 | 16 | 150 | 2 | EFO_0000668, MONDO_0024664 | |
| Disease | body mass index, type 2 diabetes mellitus | 2.94e-03 | 16 | 150 | 2 | EFO_0004340, MONDO_0005148 | |
| Disease | otitis media (biomarker_via_orthology) | 3.32e-03 | 17 | 150 | 2 | DOID:10754 (biomarker_via_orthology) | |
| Disease | serum albumin measurement | 3.38e-03 | 592 | 150 | 9 | EFO_0004535 | |
| Disease | triglycerides in VLDL measurement | 3.40e-03 | 59 | 150 | 3 | EFO_0022326 | |
| Disease | colorectal cancer (is_implicated_in) | 3.44e-03 | 121 | 150 | 4 | DOID:9256 (is_implicated_in) | |
| Disease | C-reactive protein measurement | CUX2 ARHGAP10 R3HDM2 SSPOP PHF21A MAP3K1 MLXIPL IGF2BP1 ZMIZ2 SEC16A JAZF1 KDM2B NEURL1B BSN | 3.46e-03 | 1206 | 150 | 14 | EFO_0004458 |
| Disease | protein-glutamine gamma-glutamyltransferase e measurement | 3.56e-03 | 60 | 150 | 3 | EFO_0020690 | |
| Disease | cholesterol in chylomicrons and extremely large VLDL measurement | 3.56e-03 | 60 | 150 | 3 | EFO_0021898 | |
| Disease | cholesterol to total lipids in medium HDL percentage | 3.56e-03 | 60 | 150 | 3 | EFO_0022237 | |
| Disease | cortical surface area measurement | NYAP2 CTTNBP2 PODXL ZC3H13 DAB1 PHF21A MAP3K1 IGF2BP1 NOL4L PRRC2C VCAN NAV1 ZFHX3 SOS2 RAD23B | 3.63e-03 | 1345 | 150 | 15 | EFO_0010736 |
| Disease | ischemia (biomarker_via_orthology) | 3.72e-03 | 18 | 150 | 2 | DOID:326 (biomarker_via_orthology) | |
| Disease | triglycerides in small VLDL measurement | 3.74e-03 | 61 | 150 | 3 | EFO_0022145 | |
| Disease | Precursor Cell Lymphoblastic Leukemia Lymphoma | 3.74e-03 | 61 | 150 | 3 | C1961102 | |
| Disease | free cholesterol in very large VLDL measurement | 3.74e-03 | 61 | 150 | 3 | EFO_0022274 | |
| Disease | parental longevity | 3.88e-03 | 494 | 150 | 8 | EFO_0007796 | |
| Disease | triglycerides in small HDL measurement | 3.91e-03 | 62 | 150 | 3 | EFO_0022158 | |
| Disease | cystic fibrosis (is_marker_for) | 3.91e-03 | 62 | 150 | 3 | DOID:1485 (is_marker_for) | |
| Disease | triglycerides in medium LDL measurement | 3.91e-03 | 62 | 150 | 3 | EFO_0022322 | |
| Disease | triglycerides to total lipids in very large HDL percentage | 3.91e-03 | 62 | 150 | 3 | EFO_0022339 | |
| Disease | total lipids in very large VLDL measurement | 3.91e-03 | 62 | 150 | 3 | EFO_0022313 | |
| Disease | free cholesterol in chylomicrons and extremely large VLDL measurement | 3.91e-03 | 62 | 150 | 3 | EFO_0022263 | |
| Disease | phospholipids in very large VLDL measurement | 3.91e-03 | 62 | 150 | 3 | EFO_0022299 | |
| Disease | optic disc size measurement | 4.04e-03 | 205 | 150 | 5 | EFO_0004832 | |
| Disease | free cholesterol to total lipids in medium LDL percentage | 4.09e-03 | 63 | 150 | 3 | EFO_0022283 | |
| Disease | mean arterial pressure | 4.12e-03 | 499 | 150 | 8 | EFO_0006340 | |
| Disease | sexual dimorphism measurement | NYAP2 PODXL PTPN23 E2F1 PHF21A MLXIPL SSC5D SCMH1 FER1L4 SEC16A JAZF1 ZFHX3 BSN | 4.34e-03 | 1106 | 150 | 13 | EFO_0021796 |
| Disease | triglycerides in small LDL measurement | 4.47e-03 | 65 | 150 | 3 | EFO_0022323 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PPASTPTSPSSPGLS | 6 | Q15173 | |
| TTSSPPATQPTRPPT | 1281 | P13611 | |
| SPPSTPPRRPDTSTS | 151 | Q8N9M1 | |
| STAVPTPATTPAPAP | 501 | Q9Y3L3 | |
| VPPTAPSPAPSLVAS | 1041 | O00468 | |
| TPSSGPPSTPTLIPA | 361 | Q5H9F3 | |
| PNITPSSSPSPVPAT | 966 | Q68CP9 | |
| SLPSPTSAPPGTPTQ | 1881 | Q92793 | |
| VTTPVSPAPTTPVTP | 326 | Q5T2E6 | |
| SPAPTTPVTPLGTTP | 331 | Q5T2E6 | |
| PDSPSSTPTPSPVSR | 91 | O94989 | |
| PVVTPTASTAPPVPA | 506 | O60641 | |
| TASTAPPVPATAPSP | 511 | O60641 | |
| SSPIPYTPSPSSSRP | 351 | Q16204 | |
| TRTPSSSPPITPPAS | 506 | Q9NZJ0 | |
| SPVPSSSAPISPSPP | 1411 | O14529 | |
| TPAPSTASPTTQPPT | 371 | O43155 | |
| PSAVSPIPAVIPSPS | 601 | Q9ULK2 | |
| TSPTPPVVSSTPPTG | 331 | Q9NYB9 | |
| PTSTTSSSPIPPSPA | 261 | O75175 | |
| SPTPIPTVTAPSPRA | 31 | Q13434 | |
| ATPSSSPGTALTPPV | 2061 | Q9HC84 | |
| TTNPSSTPGTTPIPP | 2146 | Q9HC84 | |
| PSSTPGTTPIPPVLT | 2706 | Q9HC84 | |
| PSSTPGTTPIPPVLT | 3406 | Q9HC84 | |
| TNPSSTPGTTPIPPV | 3961 | Q9HC84 | |
| TATPSSTPGTAPPPK | 4266 | Q9HC84 | |
| PPVSSAPLSSPSPAP | 4991 | Q9HC84 | |
| TPPTASPAAPVSSTP | 5266 | Q9HC84 | |
| SPVTSPTQSPAPSPV | 761 | Q9Y2K5 | |
| PAPSSTPTPTAPIAT | 396 | Q9P2K3 | |
| PTPVPALAPTSTPAS | 111 | P54727 | |
| GSSPVPSSTAPKTPS | 576 | Q9H1K0 | |
| PPAPPVTHSTPVTVS | 291 | P43351 | |
| PASLPESTPIPSSSP | 1531 | Q9H3S7 | |
| ESTPIPSSSPPPLSS | 1536 | Q9H3S7 | |
| SSSTLPVPQPSSAPP | 971 | Q08999 | |
| ASPPASPPTSSVGTT | 561 | Q7Z6G8 | |
| LSSPSPVTTAVPGPP | 641 | A1A4S6 | |
| TSPSPVPTTLPESRP | 6521 | Q8WXI7 | |
| PPTPPSITSTGLTSP | 936 | Q99102 | |
| PSSPSPSPSPSQNAT | 21 | O00592 | |
| PLPSASTSPAPTTVP | 621 | Q7Z4F1 | |
| VSPSKSPSLSPSPPS | 1251 | P46821 | |
| STIPAPTTTPPAPAS | 176 | Q9Y5Y7 | |
| PTTTPPAPASTSIPR | 181 | Q9Y5Y7 | |
| LSPATPTPAAPTSPL | 381 | Q9H3P2 | |
| PTSRDPLPSVPPTTT | 601 | Q8N307 | |
| FPASSSAVPPPPSSV | 376 | Q9NZI8 | |
| PPSLTTSTLASPSPP | 656 | O75145 | |
| PSSTTSSTPSSPAPP | 521 | Q6VAB6 | |
| SSTPSSPAPPLPPSA | 526 | Q6VAB6 | |
| TPPETLPPGSSSPTV | 1401 | A9Z1Z3 | |
| GSLTPPVTPPITPSS | 106 | Q86VZ6 | |
| HTPPTPPTPTTSSSN | 541 | O15054 | |
| SSPPLSPSSPSESPT | 1476 | Q9UPA5 | |
| PFPTSSNPSSATTPP | 461 | Q8IVT5 | |
| SRPTPAPTATPTAPS | 231 | O00330 | |
| TPITPPASTTTLPPT | 1506 | Q02817 | |
| PASTTTLPPTTTPSP | 1511 | Q02817 | |
| LPPSITPPTFSPFST | 1761 | Q02817 | |
| HTLSPPPSTTTSPPG | 4266 | Q02817 | |
| CPSTPSPTPTPSKST | 4376 | Q02817 | |
| LSPPSASPVPTPAVS | 331 | Q7L5A3 | |
| APAPVPQSSTPFSSP | 531 | Q8TEB1 | |
| SSPSTSPPSALPPDV | 1041 | Q8TDM6 | |
| PPANAATSTPAPSPS | 651 | Q96BD5 | |
| SIPSVTPPPPATTNS | 431 | P09086 | |
| LPAVSSPPAPVSPSS | 401 | O43896 | |
| PTTPVATTVPAPTTP | 156 | Q9H1U4 | |
| ATTVPAPTTPRTPTP | 161 | Q9H1U4 | |
| APTTPRTPTPDLPSS | 166 | Q9H1U4 | |
| PPVTSSATTTSVAPP | 1386 | P35658 | |
| TNSTVPPSAPPPTTA | 1446 | P35658 | |
| PPTTAATPLPTSFPT | 1456 | P35658 | |
| STPVTAVPPSRLSPP | 291 | Q68G74 | |
| STLPTTPAPQPPTSS | 326 | Q93074 | |
| TTPVPPTTFSFSTPP | 1321 | P98088 | |
| TFSTPSPPPVPATST | 1536 | P98088 | |
| STPSPPPVPATSTSS | 1911 | P98088 | |
| CPVTSTPVTAPSTPS | 3326 | P98088 | |
| ATPALSSSPPPPSTL | 406 | Q9P242 | |
| SSNGLPPSPIPSPTT | 166 | Q96E09 | |
| PATSPTPLSDSTPGI | 66 | Q96PH6 | |
| PTPTPSSTSTSRPVP | 381 | Q96MY1 | |
| SPTSSVSPGSPPSSP | 546 | Q3MIN7 | |
| QSRSPPAVPSPPSST | 1611 | P42694 | |
| TAASTTPTPPTAPTP | 3496 | Q7Z6Z7 | |
| VLPPSFSPSPSSAPS | 56 | Q8TDS5 | |
| PSATPTAATPTPGPT | 371 | Q86XN7 | |
| TATAATTTAPPPPPA | 96 | Q8IZL2 | |
| TAAPPTPSATTPAPP | 166 | Q8TAX7 | |
| TPSATTPAPPSSSAP | 171 | Q8TAX7 | |
| TPAPPSSSAPPETTA | 176 | Q8TAX7 | |
| SSSAPPETTAAPPTP | 181 | Q8TAX7 | |
| APPTPSATTQAPPSS | 191 | Q8TAX7 | |
| TTAAPPTPPATTPAP | 211 | Q8TAX7 | |
| PTPPATTPAPPSSSA | 216 | Q8TAX7 | |
| TTPAPPSSSAPPETT | 221 | Q8TAX7 | |
| PSSSAPPETTAAPPT | 226 | Q8TAX7 | |
| PPETTAAPPTPSATT | 231 | Q8TAX7 | |
| AAPPTPSATTPAPLS | 236 | Q8TAX7 | |
| PSATTPAPLSSSAPP | 241 | Q8TAX7 | |
| SSAPPETTAVPPTPS | 251 | Q8TAX7 | |
| TAAPPTPSATTPAPP | 281 | Q8TAX7 | |
| TPSATTPAPPSSPAP | 286 | Q8TAX7 | |
| TPTAAPPTLPPTTVG | 1031 | O94856 | |
| SSSSKAPPPSLPSPS | 136 | Q6NT52 | |
| PKPPTDGSTSPTSTP | 436 | Q8NHM5 | |
| PVPETTPTPPTKTGT | 436 | O15234 | |
| DSATIVSPPPSSPPS | 326 | Q01094 | |
| VSPPPSSPPSSLTTD | 331 | Q01094 | |
| TSTTPSTNSPPTPAP | 506 | O75553 | |
| PSTGSTPDPTSSTPP | 386 | Q8WZ74 | |
| TPDPTSSTPPLPSNA | 391 | Q8WZ74 | |
| SSTPPLPSNAAPPTA | 396 | Q8WZ74 | |
| IPSVGSPASSTPLPP | 286 | O00512 | |
| SPPPQTSSSAPPNTS | 176 | Q6K0P9 | |
| NPSLPFTSSPDPTPS | 1066 | Q86UU0 | |
| PSQPPTPATAPSTTE | 326 | Q6P1N0 | |
| PSVPSPVSLSSPGTP | 11 | P10075 | |
| PSGTPISPAPVPSTL | 971 | P00519 | |
| SHSTPPLAPATPTPS | 116 | Q674R7 | |
| ESQPSSPSPTPSPSP | 256 | Q04637 | |
| SPTTPEPTPIPTIAT | 446 | P07359 | |
| PSPTNSSSPSPRDPT | 356 | Q6ZN01 | |
| SQPGSPSPKTPTPST | 1531 | Q14839 | |
| PSPKTPTPSTPGDTQ | 1536 | Q14839 | |
| SPSARPISSPPPETS | 191 | O15255 | |
| PTSPPAGSSSPSQPT | 26 | Q9Y238 | |
| TNFSSPISPPSPLTP | 366 | Q9Y2W3 | |
| SSPSPPPLSAISSVV | 1071 | Q13029 | |
| PVAVASPSLPSPPVS | 316 | P78415 | |
| PSSVPSGLPPSATPS | 46 | Q8NDC0 | |
| AASPPASSTSPSPEP | 81 | Q13233 | |
| SSAARVPPVPTSPSP | 196 | Q504T8 | |
| SAFPSSTPVPTPPAP | 896 | Q8NEY1 | |
| SPAPVSPREPSSSPS | 81 | Q5TD94 | |
| KASPPPSPAPSSSSS | 571 | Q8N1G1 | |
| SPTDSPSSLPPLPSS | 556 | Q6WKZ4 | |
| PGTTPLPPPTTAETS | 416 | Q12872 | |
| PSSPLPSVPVSVPAS | 491 | Q494U1 | |
| SAPTSPNTPSTPPVS | 1081 | Q07890 | |
| SPTSPTETRPVSPGP | 2316 | A2VEC9 | |
| PPLPAGPPSSSSSSS | 41 | P78426 | |
| PTTTTQSPAASPPPH | 766 | O14827 | |
| PVASTPSSTPIPALS | 431 | Q7Z3K3 | |
| PALPSPASTATPPPT | 906 | Q7Z3K3 | |
| SPLTTPPPETPSSIA | 796 | Q9H6K5 | |
| ITSPLPSVSSPPPAS | 446 | Q8NEB9 | |
| PVPASTSAPVPASTL | 1776 | Q9Y520 | |
| DSTPPSSSPKIPSGP | 281 | Q8IZD0 | |
| ASPSPTSRQSPASPP | 1436 | Q14160 | |
| TPGPTPVSVLPSSTP | 1266 | Q6ZRS2 | |
| PVSVLPSSTPSTTPA | 1271 | Q6ZRS2 | |
| SPVPAPTPVLAPSST | 1646 | Q6ZRS2 | |
| TTPHPTTPDPSSTPV | 1321 | A1L4H1 | |
| PPPPSSTFPKASSES | 551 | Q86SQ0 | |
| SPPTLAPATASPPTT | 506 | Q9NP71 | |
| APLTSDPPTPPSSTP | 491 | Q9NZP6 | |
| RATSPTPSSRSPAPP | 286 | Q9NZ20 | |
| TLLNPPPASPTTSTP | 321 | Q96GD3 | |
| VTPPPSSPVTTGPSF | 366 | Q7Z6J0 | |
| SAPTTPVPPTTASPV | 306 | Q8N365 | |
| PATATPAPTSPFPSA | 1141 | Q96RK0 | |
| PLPAAVVPSTPTSAP | 661 | Q6ZRI6 | |
| PTSAPSAPPSTPTPS | 106 | Q8IWZ8 | |
| SSTPAPTIIPAPAAP | 356 | Q8IWZ8 | |
| PASSSAPPATPPTSG | 126 | P23246 | |
| SPPSSPPSLSLPSTV | 3491 | Q86UP3 | |
| APPTPASSSSAAPPT | 21 | Q8N377 | |
| AAPPTPASSSSAAPP | 31 | Q8N377 | |
| PTPKPTVSPSSSSPN | 1081 | Q6ZU65 | |
| AVATSTAAPPPPSSP | 441 | Q14157 | |
| PSFPTATSPAPPIIS | 61 | Q9H3R2 | |
| GSVSQPSTPSPPKPT | 586 | O15027 | |
| PLAPAAPTPPSVTVS | 2806 | Q15772 | |
| APTPPSVTVSPSSPP | 2811 | Q15772 | |
| SVTVSPSSPPTPPSQ | 2816 | Q15772 | |
| PSSPPTPPSQALSSL | 2821 | Q15772 | |
| TTPVLAPTPAPVPAS | 386 | A0A1B0GUW6 | |
| SEASLSPPSSPPSRP | 1266 | Q7Z4S6 | |
| PPPAPSSASSSPSPS | 186 | Q9H7N4 | |
| TPPITTIAAAPPPSV | 751 | Q9H0E3 | |
| TAPSSPLSPPVSPVF | 476 | A8MQ27 | |
| APPASSSAPTSAPPL | 1291 | Q5T1R4 | |
| PLTSPSSPTPPSTSG | 496 | Q7Z7A4 | |
| SSSSPFSNRPPLPPT | 241 | O43516 | |
| PRPSSPAVTSLASPP | 106 | Q1RN00 | |
| APSSSSPSPSPSARP | 1166 | Q92797 | |
| TFPESFPPTTPSTPT | 756 | Q8NF64 | |
| PLPPSLSSVTSPSLP | 56 | P58753 | |
| PSLPAAPAPSTVTPA | 181 | Q9P2F9 | |
| PSPESSASPVPSTQP | 1091 | Q9HAU0 | |
| TSSPATSFPPPPSSG | 936 | O94979 | |
| STVQSLSPTPSPPTP | 751 | Q6ZS17 | |
| TPDPASAPSTTPASP | 101 | Q9NRR5 | |
| PPTVAPSSPSVVPVA | 466 | Q9UPU7 | |
| SPASPSSSPTPASPE | 201 | P53814 | |
| TPSPSPPCSSSPSPS | 401 | O75385 | |
| PSPVSPTFPPSSPSD | 971 | Q63HR2 | |
| LPPPPPVATATATTV | 1101 | Q5T200 | |
| TPAIPASAPPITSPT | 2061 | Q15911 | |
| SAPTSAPAPVSAPVP | 326 | Q9H5J0 | |
| PSPKGTPTLPATTPS | 1341 | E9PAV3 |